WO2015007146A1 - Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof - Google Patents
Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof Download PDFInfo
- Publication number
- WO2015007146A1 WO2015007146A1 PCT/CN2014/080941 CN2014080941W WO2015007146A1 WO 2015007146 A1 WO2015007146 A1 WO 2015007146A1 CN 2014080941 W CN2014080941 W CN 2014080941W WO 2015007146 A1 WO2015007146 A1 WO 2015007146A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- derivatives
- camphor
- ultraviolet
- salicylate
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract description 12
- 239000002250 absorbent Substances 0.000 title abstract description 7
- 230000002745 absorbent Effects 0.000 title abstract description 7
- 230000006750 UV protection Effects 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 74
- 210000004209 hair Anatomy 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- -1 Diethanolamine ester Chemical class 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 39
- 239000006096 absorbing agent Substances 0.000 claims description 21
- 239000002537 cosmetic Substances 0.000 claims description 19
- 150000002148 esters Chemical class 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000516 sunscreening agent Substances 0.000 claims description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 9
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 9
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 8
- 241000723346 Cinnamomum camphora Species 0.000 claims description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- 229960000846 camphor Drugs 0.000 claims description 8
- 229930008380 camphor Natural products 0.000 claims description 8
- 239000003906 humectant Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 229920005862 polyol Polymers 0.000 claims description 5
- 150000003077 polyols Chemical class 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 4
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 claims description 4
- 229940063655 aluminum stearate Drugs 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 4
- 150000004706 metal oxides Chemical class 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- 241000195940 Bryophyta Species 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 3
- 150000001565 benzotriazoles Chemical class 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 235000011929 mousse Nutrition 0.000 claims description 3
- 229960001679 octinoxate Drugs 0.000 claims description 3
- 239000003380 propellant Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical class [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 claims description 2
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 claims description 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 claims description 2
- OSJVRHJQUTTZIN-UHFFFAOYSA-N 2-ethoxyethyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CCOCCOC(=O)C(OC)=CC1=CC=CC=C1 OSJVRHJQUTTZIN-UHFFFAOYSA-N 0.000 claims description 2
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 claims description 2
- IPNFHEWNDOORKH-UHFFFAOYSA-N 6-methylheptyl 2-hydroxybenzoate Chemical compound CC(C)CCCCCOC(=O)C1=CC=CC=C1O IPNFHEWNDOORKH-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- XQFHLTFOBJNUHU-UHFFFAOYSA-N C1=CC(OC)(OC)CC(O)=C1C(=O)C1=CC=CC=C1O Chemical compound C1=CC(OC)(OC)CC(O)=C1C(=O)C1=CC=CC=C1O XQFHLTFOBJNUHU-UHFFFAOYSA-N 0.000 claims description 2
- 230000003113 alkalizing effect Effects 0.000 claims description 2
- 229960002709 amiloxate Drugs 0.000 claims description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims description 2
- 229920006318 anionic polymer Polymers 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims description 2
- 239000012965 benzophenone Substances 0.000 claims description 2
- 150000008366 benzophenones Chemical class 0.000 claims description 2
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 claims description 2
- 229920006317 cationic polymer Polymers 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- WQQOKAKJKDTIBY-UHFFFAOYSA-N diethyl 2-[(4-ethoxyanilino)methylidene]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)=CNC1=CC=C(OCC)C=C1 WQQOKAKJKDTIBY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 229960004697 enzacamene Drugs 0.000 claims description 2
- BMOAQMNPJSPXIU-UHFFFAOYSA-N ethyl 2-(3-fluoro-4-nitrophenyl)propanoate Chemical compound CCOC(=O)C(C)C1=CC=C([N+]([O-])=O)C(F)=C1 BMOAQMNPJSPXIU-UHFFFAOYSA-N 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000010408 film Substances 0.000 claims description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 claims description 2
- 229960003921 octisalate Drugs 0.000 claims description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 2
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001173 oxybenzone Drugs 0.000 claims description 2
- 229960001860 salicylate Drugs 0.000 claims description 2
- 150000003902 salicylic acid esters Chemical class 0.000 claims description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000368 sulisobenzone Drugs 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- ISDGWTZFJKFKMO-UHFFFAOYSA-N 2-phenyl-1,3-dioxane-4,6-dione Chemical class O1C(=O)CC(=O)OC1C1=CC=CC=C1 ISDGWTZFJKFKMO-UHFFFAOYSA-N 0.000 claims 2
- 150000001343 alkyl silanes Chemical class 0.000 claims 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims 2
- 229910001928 zirconium oxide Inorganic materials 0.000 claims 2
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 claims 1
- ATAQMBQQINQEJY-UHFFFAOYSA-N 2-(4-methoxyphenyl)-1,3-dioxane-4,6-dione Chemical compound C1=CC(OC)=CC=C1C1OC(=O)CC(=O)O1 ATAQMBQQINQEJY-UHFFFAOYSA-N 0.000 claims 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 claims 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 claims 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 claims 1
- 239000012964 benzotriazole Substances 0.000 claims 1
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 125000005375 organosiloxane group Chemical group 0.000 claims 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 5
- 230000007547 defect Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000000191 radiation effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- 210000003491 skin Anatomy 0.000 description 25
- 235000019198 oils Nutrition 0.000 description 16
- 235000002639 sodium chloride Nutrition 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 230000000475 sunscreen effect Effects 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229940041616 menthol Drugs 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 229940048053 acrylate Drugs 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 230000035597 cooling sensation Effects 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 6
- 239000005642 Oleic acid Substances 0.000 description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 5
- 235000006679 Mentha X verticillata Nutrition 0.000 description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 229940044199 carnosine Drugs 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- CUSUFTNOPPMGBK-UHFFFAOYSA-N decyl benzoate Chemical compound CCCCCCCCCCOC(=O)C1=CC=CC=C1 CUSUFTNOPPMGBK-UHFFFAOYSA-N 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940071160 cocoate Drugs 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 210000004243 sweat Anatomy 0.000 description 4
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 108010087806 Carnosine Proteins 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- 229940031578 diisopropyl adipate Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 3
- 229960002248 meradimate Drugs 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 2
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical compound OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- ODXRBRHXHHSJPK-UHFFFAOYSA-N N-benzoyl-N-methanimidoylbenzamide Chemical class C(C1=CC=CC=C1)(=O)N(C=N)C(C1=CC=CC=C1)=O ODXRBRHXHHSJPK-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229940056099 polyglyceryl-4 oleate Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- BGKZULDOBMANRY-UHFFFAOYSA-N sulfanyl prop-2-enoate Chemical compound SOC(=O)C=C BGKZULDOBMANRY-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OPTYCEAUVSDMAT-UHFFFAOYSA-N (3-hydroxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)CO OPTYCEAUVSDMAT-UHFFFAOYSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- XUEHUKMVOSJLFC-UHFFFAOYSA-N (5-methyl-2-propan-2-ylcyclohexyl) 4-aminobenzoate Chemical compound CC(C)C1CCC(C)CC1OC(=O)C1=CC=C(N)C=C1 XUEHUKMVOSJLFC-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- GLHKHBCFIYOKAZ-UHFFFAOYSA-N 2-[(4-ethoxyanilino)methylidene]propanedioic acid Chemical compound CCOC1=CC=C(NC=C(C(O)=O)C(O)=O)C=C1 GLHKHBCFIYOKAZ-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- VFZKVQVQOMDJEG-UHFFFAOYSA-N 2-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(=O)C=C VFZKVQVQOMDJEG-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- XWHIOJOWXZILNH-UHFFFAOYSA-N 4,7,7-trimethyl-2-methylidenebicyclo[2.2.1]heptan-3-one Chemical class C1CC2(C)C(=O)C(=C)C1C2(C)C XWHIOJOWXZILNH-UHFFFAOYSA-N 0.000 description 1
- DAMJHRQAZOFKBS-UHFFFAOYSA-N 4-decoxy-2,3-dihydroxy-4-oxobutanoic acid Chemical compound CCCCCCCCCCOC(=O)C(O)C(O)C(O)=O DAMJHRQAZOFKBS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CKNYEUXAXWTAPK-UHFFFAOYSA-N 4-octoxy-4-oxobutanoic acid Chemical compound CCCCCCCCOC(=O)CCC(O)=O CKNYEUXAXWTAPK-UHFFFAOYSA-N 0.000 description 1
- HZXDXQJVKPSOJJ-UHFFFAOYSA-N 4-octyl-N-(6-oxo-1H-triazin-5-yl)dodecanamide Chemical compound C(CCCCCCC)C(CCC(=O)NC=1C(NN=NC=1)=O)CCCCCCCC HZXDXQJVKPSOJJ-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- BCNMHJYHRSTPJY-UHFFFAOYSA-N 8-methylnonyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC(C)C BCNMHJYHRSTPJY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 0 CC(C)C1C(*)CC(C)CC1 Chemical compound CC(C)C1C(*)CC(C)CC1 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N COc1ccc(/C=C/C=O)cc1 Chemical compound COc1ccc(/C=C/C=O)cc1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-M D-glycerate Chemical compound OC[C@@H](O)C([O-])=O RBNPOMFGQQGHHO-UWTATZPHSA-M 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000251784 Heterodontus francisci Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000577 Silicon-germanium Inorganic materials 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- IHUMNXSBUOIDQI-UHFFFAOYSA-N Triethanolamine myristate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCC(O)=O IHUMNXSBUOIDQI-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical class CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- YMOONIIMQBGTDU-SREVYHEPSA-N [(z)-2-bromoethenyl]benzene Chemical compound Br\C=C/C1=CC=CC=C1 YMOONIIMQBGTDU-SREVYHEPSA-N 0.000 description 1
- LGIYXCQTSKSBHB-UHFFFAOYSA-N [Ge].C(CCCCCCCCC)[Si] Chemical compound [Ge].C(CCCCCCCCC)[Si] LGIYXCQTSKSBHB-UHFFFAOYSA-N 0.000 description 1
- NADJZFSAACUKRC-UHFFFAOYSA-N [SiH3]O[SiH2]O[SiH3].N1N=NC2=C1C=CC=C2 Chemical compound [SiH3]O[SiH2]O[SiH3].N1N=NC2=C1C=CC=C2 NADJZFSAACUKRC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000012174 chinese wax Substances 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- FUGCGCXGFWNOSY-UHFFFAOYSA-N decyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCOC(=O)C(C)O FUGCGCXGFWNOSY-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- AWIJRPNMLHPLNC-UHFFFAOYSA-N methanethioic s-acid Chemical compound SC=O AWIJRPNMLHPLNC-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- RYNIOUSRQMXJJZ-UHFFFAOYSA-N octan-3-yl 4-(dimethylamino)benzoate Chemical compound CCCCCC(CC)OC(=O)C1=CC=C(N(C)C)C=C1 RYNIOUSRQMXJJZ-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- CGJOFAPLHYOSEP-UHFFFAOYSA-N octanoic acid phthalic acid Chemical compound C(CCCCCCC)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)O CGJOFAPLHYOSEP-UHFFFAOYSA-N 0.000 description 1
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical compound CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 description 1
- QTDSLDJPJJBBLE-PFONDFGASA-N octyl (z)-octadec-9-enoate Chemical compound CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC QTDSLDJPJJBBLE-PFONDFGASA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940102545 peg-20 sorbitan isostearate Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- UFEJXQWSRLAIOY-UHFFFAOYSA-N phenyl 1h-benzimidazole-2-sulfonate Chemical compound N=1C2=CC=CC=C2NC=1S(=O)(=O)OC1=CC=CC=C1 UFEJXQWSRLAIOY-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- VAKMIIPDYZXBEV-DPMBMXLASA-M potassium;(z,12r)-12-hydroxyoctadec-9-enoate Chemical compound [K+].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O VAKMIIPDYZXBEV-DPMBMXLASA-M 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000152 severe skin burn Toxicity 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- GKAVWWCJCPVMNR-UHFFFAOYSA-N tridecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCC GKAVWWCJCPVMNR-UHFFFAOYSA-N 0.000 description 1
- SMYKBXMWXCZOLU-UHFFFAOYSA-N tris-decyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCCCC)C(C(=O)OCCCCCCCCCC)=C1 SMYKBXMWXCZOLU-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- This invention relates to novel UV-B UV absorbers (sunscreens) and to compositions, particularly topical compositions, containing the above UV-B UV absorbers.
- UV rays are designated as UV-A rays (320-400 nm) and UV-B rays (280-320 nm).
- UV-A rays 320-400 nm
- UV-B rays 280-320 nm
- the damage of UV rays to human skin increases as the wavelength decreases and the duration of exposure increases, so UV rays can cause skin damage, and UV-B radiation can cause sunburn (erythema) to very severe skin burns.
- Sunlight's very frequent and unprotected exposure to the skin can also result in loss of skin elasticity and increased wrinkle formation, which can lead to premature aging of the skin and, in extreme cases, pathological skin changes to skin cancer.
- UV-A rays can penetrate deeper into the skin layer and accelerate the skin aging process, which can cause the skin to form pigments quickly and weakly, and also cause skin photosensitivity or photoallergic reactions, in UV-A irradiation and increased There is a definite link between skin cancer risks.
- UV absorbers for cosmetic and dermatological preparations are classified into UV-A absorbents and UV-B absorbents depending on their position of maximum absorption. Although there are a large number of safe and effective UV-B absorbers, there are few UV-A absorbers suitable for protecting human skin, and they are affected by major defects. To date, many compounds have been proposed for skin protection (UV-A and/or UV-B).
- An oil-in-oil emulsion ie, a cosmetically acceptable carrier consisting of a continuously dispersed aqueous phase and a discontinuously dispersed oil phase
- sunscreen compositions which are water-based.
- An oil-in-oil emulsion ie, a cosmetically acceptable carrier consisting of a continuously dispersed aqueous phase and a discontinuously dispersed oil phase
- these UV absorbers are lipophilic and/or hydrophilic, and selectively absorb harmful UV light of one or more classical organic UV absorbers having an aromatic function, these UV absorbers (and amounts thereof) being selected according to the required protection index (protection index (IP) is used numerically
- the irradiation time necessary to reach the erythema generation threshold in the UV ultraviolet absorber is expressed as the ratio of the time required to reach the erythema generation threshold when no UV ultraviolet absorber is present.
- these compounds with UV activity should also have good cosmetic properties in compositions containing them, with good solubility in common solvents, especially in fatty materials such as oils and fats. This is especially true, as well as having good water and sweat resistance (stagnation) properties.
- aromatic compounds specifically, a P-aminobenzoic acid derivative, a methylene camphor derivative, a cinnamic acid derivative, and a benzotriazole derivative can be cited.
- some of these materials do not possess any of the properties required for use as a UV absorber in sunscreen compositions.
- Mint has a cooling effect, which can alleviate the feeling of high heat discomfort of the skin to some extent.
- peppermint has a distinct irritating smell. It has a certain stimulating effect on the skin.
- the mint has a strong volatility and a short-acting effect, especially when it is applied to the skin near the eyes, it will have significant irritation to the eyes.
- a new type of cooling agent such as an ester of menthol, an ether, a menthyl formamide and a ketal compound of menthol, especially a high-boiling mint, is obtained by modifying the molecular structure of the mint.
- Ester derivatives have better structural stability, greatly reduce the volatility and oxidizability of menthol, mild and long-lasting cooling effect, almost odorless products, and good compatibility with many surfactants in daily chemical formulations. It is particularly favored, such as the US FDA approval of menthyl anthranilate as an ultraviolet absorber.
- these modified and improved mint products have weak UV protection effects and require a large amount of use to effectively protect them, or as an additional additive to the protective agent product, resulting in complicated production, increased product quality control, and increased cost. . Therefore, it is necessary to find a novel compound which has both desired physical and chemical properties, a strong anti-violet effect, and a continuous, cool and refreshing property.
- the first aspect of the present invention provides an anti-ultraviolet absorption compound, or a cis-trans isomer or a stereoisomer thereof, having the following structure:
- the compound of the formula (1) is preferably a trans isomer thereof, that is, a compound having the following formula (2):
- the compound of the formula (2) is preferably racemic or left-handed, that is, a compound having the following formulas (3) and (4):
- the compounds of the invention have good improved properties, especially their good fat solubility (not easily eroded or eluted by water or sweat, and can be used in products with higher concentrations to achieve extremely high or desired protection indices), strong Effective anti-UV radiation effect, cool and refreshing feeling, simple formula and convenient preparation method, as well as excellent chemical stability (good hydrolysis resistance in both acidic and alkaline media) ) making it particularly suitable for UV protection of the skin and/or hair.
- a second aspect of the invention relates to a cosmetic composition
- a cosmetic composition comprising the ultraviolet absorbers of formula (1)-(4).
- Such compositions may be in the form of emulsions, thickening lotions, creams, gels, solutions, dry powders, films, solid sticks and aerosols.
- UV-A and UV-B UV absorbers may be added to the cosmetic and/or skin care compositions of the present invention, and the different UV UV absorber combinations may also exhibit synergistic effects.
- the total amount of UV UV absorber is not critical.
- a suitable amount may be from 0.5 to 20% by weight, preferably from 0.5 to 12% by weight, based on the total amount of the composition.
- Suitable UV-B UV absorbers which may be added to the UV-A UV absorber of the present invention are the following organic or inorganic compounds:
- An acrylate such as 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, 2-cyano-3,3-diphenyl acrylate or the like;
- camphor derivatives such as 4-methylbenzylidene camphor, 3-benzylidene camphor, camphor benzalkonium methyl sulfate, polyacrylamidomethylbenzylidene camphor, thiobenzylidene camphor, thioformate Lysobenzyl camphor, p-phenylidene camphorsulfonic acid, etc.;
- cinnamate derivatives such as octyl methoxycinnamate, ethoxyethyl methoxycinnamate, diethanolamine methoxycinnamate, isoamyl methoxycinnamate, etc., and attached to siloxanes a cinnamic acid derivative;
- p-aminobenzoic acid derivatives such as p-aminobenzoic acid, p-dimethylaminobenzoic acid-ethylhexyl ester, N-oxyally acrylated ethyl p-aminobenzoate, p-aminobenzoic acid;
- Benzophenones such as benzophenone-3, benzophenone-4, 2,2',4,4'-tetrahydroxy-benzophenone, 2,2'-dihydroxy-4,4-dimethoxy Benzophenone
- An ester of 2-(4-ethoxy-anilinomethylidene)-malonic acid such as 2-(4-ethoxy-anilinomethylidene)-malonic acid diethyl ester;
- Pigments such as particulate titanium dioxide, etc.
- the term “particulate” means a particle size of from about 5 nm to about 200 nm, especially from about 15 nm to about 100 nm, and the titanium dioxide particles may also be coated with a metal oxide such as alumina or zirconia, or coated Organic coatings such as polyols, methyl silicone oils, aluminum stearate, decyl silicon germanium, and the like. These coatings are well known in the art.
- Imidazole derivatives such as 2-phenylbenzimidazolesulfonic acid and salts thereof.
- the 2-phenyl benzimidazole sulfonate for example, an alkali metal salt such as a sodium or potassium salt, an ammonium salt, a morpholine salt, a primary amine salt, a secondary amine salt and a tertiary amine salt such as a monoethanolamine salt, a diethanolamine salt or the like.
- Salicylate derivatives such as isopropyl benzyl salicylate, benzyl salicylate, butyl salicylate, octyl salicylate, isooctyl salicylate or high maleuryl salicylate.
- Triazinone derivatives such as octyltriazinone, dioctylbutyrylaminotriazinone and the like.
- Suitable conventional UV-A UV absorbers which may be added to the UV-A UV absorber of the present invention are the following organic and inorganic compounds:
- Dibenzoylformamidine derivatives such as 4-tert-butyl-4'-methoxydibenzoylformamidine, dimethoxydibenzoylformamidine, isopropyldibenzoylformamidine, etc. ;
- Benzotriazole derivatives such as 2,2'-methylene-bis(6-(2H-benzotriazol)-2-yl)-4-(1,1,3,3-tetramethylbutyl) ) - phenol, etc.;
- a phenylene-1,4-dibenzimidazole sulfonic acid or salt such as 2,2-(1,4-phenylene)-di-(IH-benzimidazole-4,6-disulfonic acid);
- amino-substituted hydroxybenzophenone such as 2-(4diethylamino-2-hydroxy-benzoyl)-benzoic acid ethyl ester as described in European Patent Publication EP1046391;
- Pigments such as particulate zinc oxide.
- the term "particulate” means a particle size of from about 5 nm to about 200 nm, especially from about 15 nm to about 100 nm, and the titanium dioxide particles may also be coated with a metal oxide such as alumina or zirconia, or coated with an organic coating such as a polyol, A Base silicone oil, aluminum stearate, fluorenyl silicon germanium, and the like. These coatings are well known in the art.
- compositions of the present invention may also contain conventional cosmetic auxiliaries and additives such as preservatives/antioxidants, fatty substances/oils, water, organic solvents, silicones, thickeners, softeners, emulsifiers, defoaming agents.
- Agent humectant, perfume, surfactant, filler, chelating agent, anionic polymer, cationic polymer, nonionic polymer or amphoteric polymer or mixture thereof, propellant, acidifier or alkalizing agent, dye, colorant , pigments or nanopigments, especially those suitable for providing additional photoprotection by physical shielding of ultraviolet radiation, or any other ingredient usually formulated with cosmetics, especially Description
- antioxidants are those selected from the group consisting of amino acids (eg, glycine, histidine, tyrosine, tryptophan) and derivatives thereof; peptides such as DL-carnosine, D-carnosine, L - carnosine and derivatives (eg goose carnosine); carotenoids, carotenes (eg P-carotene, Y-carotene, lycopene) and derivatives; chlorogenic acids and derivatives; fatty acides and derivatives (eg dihydroaliphatic acid); glucosinolate, propylthiouracil and other thiols (eg glutathione, cysteine, cystine, cystine and its glycosyl-, N-acetyl) -, methyl-, ethyl-, propyl-, pentyl-, butyl- and lau
- the preservative and/or antioxidant may be present in an amount of from about 0.01% to about 10% by weight based on the total weight of the composition. Preferably, the preservative and/or antioxidant are present in an amount from about 0.1% to about 1% by weight.
- composition according to the present invention may further contain an emulsifier which can uniformly mix two or more immiscible liquids while increasing the viscosity of the composition.
- the emulsifier acts to stabilize the composition.
- Emulsifiers which can be used in accordance with the invention to form 0/W, W/O and/or 0/W/0 formulations include sorbitan oleate, sorbitan sesquioleate, iso-hard Sorbitan acid sorbitan ester, sorbitan trioleate, polyglyceryl-diisostearate, polyglycerol ester of oleic acid isostearic acid, polyglyceryl-6-hexaparale Acid ester, polyglyceryl-4-oleate, polyglyceryl-4-oleate/PEG-8 propylene glycol cocoate, oleamide DEA, TEA myristate, TEA stearate, stearic acid Magnesium, sodium stearate, potassium laurate, potassium ricinoleate, sodium covate, sodium tauroate, potassium betulinate, sodium oleate and mixtures thereof.
- emulsifiers are phosphates and salts thereof, such as cetyl phosphate, DEA cetyl phosphate, potassium hexadecanoate, sodium oleate, hydrogenated plant glyceride phosphates and Its mixture.
- one or more synthetic polymers can be used as emulsifiers, for example, PVP eicosene copolymer, acrylate/acrylic acid C10-C30 decyl ester crosspolymer, acrylate/stearyl methacrylate Copolymer, PEG-2?/dodecyl glycol copolymer, PEG-4 dodecyl glycol copolymer and mixtures thereof.
- Preferred emulsifiers are PVP eicosene copolymer, acrylate/C10-C30 decyl crosspolymer, PEG-20 sorbitan isostearate, sorbitan isostearate Esters and mixtures thereof.
- the emulsifier is present in a total amount of from about 0.01% by weight to about 45% by weight, preferably from about 0.1% to about 3% by weight based on the total weight of the composition.
- the fat/oil phase is advantageously selected from:
- oil such as triglyceride of citric acid or octanoic acid, preferably castor oil;
- a natural or synthetic oil preferably an ester of carbonic acid or a fatty acid with an alcohol such as isopropanol, propylene glycol or glycerol; • a decyl benzoate;
- Polysiloxanes such as dimethylpolysiloxane, dihexylpolysiloxane, diphenylpolysiloxane and mixtures thereof.
- the fatty substance which may be added to the oil phase of the composition of the invention is advantageously selected from the group consisting of saturated and/or unsaturated linear or branched hydrocarbyl acids having from 3 to 30 carbon atoms and saturated with from 3 to 30 carbon atoms.
- esters may advantageously be selected from the group consisting of: isostearyl neopentanoate, diethylene glycol monostearate, isobutyl p-hydroxybenzoate, acrylate C10-C30 mercapto acrylate, octyl palmitate, coconut Octyl oleate, decyl cocoate, octyl isostearate, octyldodecanyl myristate, cetyl isononate, isopropyl myristate, isopropyl palmitate, stearic acid Isopropyl ester, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isodecyl stearate, isodecyl isononanoate, brown 2-ethylhexyl acid release, 2-e
- fatty components suitable for use in the compositions of the present invention include polar oils such as lecithin and fatty acid triglycerides, i.e., saturated and/or unsaturated straight chains of 8 to 24 carbon atoms, preferably 12 to 18 carbon atoms.
- fatty acid triglyceride is preferably selected from the group consisting of synthetic oils, semi-synthetic oils and natural oils (eg cocoglycerides, olive oil, sunflower oil, soybean oil, peanut oil, vegetable oil, almond oil, palm oil) , coconut oil, castor oil, hydrogenated castor oil, wheat oil, grape oil and other oils); non-polar oils such as linear and / or branched diameter and wax, such as mineral oil, petrolatum (petrolatum); paraffin, horn Shark and squalene, polyolefin (favorable polydecene), hydrogenated polyisobutylene and isohexadecane; dimercapto acid such as dioctanoyl ether; linear or cyclic silicone oil such as cyclomethicone, Octamethylcyclotetrasiloxane, hexadecanyl dimethicone, hexamethylcyclotrisiloxane, poly
- fatty components which may be advantageously added to the compositions of the invention are isodecahedon; neopentyl glycol heptanoate; propylene glycol diacrylate/dicaprate; octyl succinate/decyl acrylate/diglyceride; octanoic acid /butylene citrate; C12-13 decyl lactate; di C12-13 decyl tartrate; isoglyceryl tristearate; hexacyanoic acid / dipentaerythritol hexarate; propylene glycol monoisostearate ; Trioctyl glycerate; Dimethyl isosorbate.
- compositions of the present invention may also contain natural vegetable waxes or animal waxes such as beeswax, Chinese wax, rhubarb and other insect waxes, and shea butter.
- compositions of the present invention may additionally contain one or more emollients.
- emollients that softens or smoothes the surface of the skin Description
- the emollient also helps to control the rate of evaporation and the viscosity of the composition.
- Preferred emollients include mineral oil, lanolin oil, coconut oil, cocoa butter, olive oil, aloe extract, jojoba oil, castor oil, fatty acids such as oleic acid and stearic acid, fatty alcohols such as cetyl alcohol or sixteen Mercapto alcohol, diisopropyl adipate, benzoate and hydroxybenzoate of C9-C15 alcohol, isodecyl isononanoate, C15-C50 anthraquinone, mineral oil, siloxane such as Methyl polysiloxane, ethers such as polyoxypropylene butyl ether and polyoxypropylene cetyl ether, and C2-C15 decyl benzoate and mixtures thereof.
- the most preferred emollients are hydroxybenzoate, aloe vera, C12
- the emollient is present in an amount from about 1% to about 20% by weight based on the total weight of the composition, preferably from about 2% to about 15% by weight, most preferably from about 4% to about 10% by weight.
- the aqueous phase of the preparation of the invention may contain customary cosmetic additives such as alcohols, especially lower alcohols, preferably ethanol and/or isopropanol, lower mercapto diols or polyols and ethers thereof, preferably propylene glycol, glycerol, ethylene Alcohol, ethylene glycol monoethyl ether or ethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether or propylene glycol monobutyl ether, diethylene glycol monomethyl ether or monoethyl ether and similar products, polymer, foam stabilizer; electrolyte And especially one or more thickeners.
- customary cosmetic additives such as alcohols, especially lower alcohols,
- Thickeners which can be used in the formulations of the present invention include silicas, magnesium silicates and/or aluminum silicates, polysaccharides and derivatives thereof such as hyaluronic acid, xanthan gum, hydroxypropyl cellulose, acrylate copolymers.
- a humectant such as a humectant, can be added to the compositions of the present invention to reduce transepidermal water loss (TEWL) in the stratum corneum of the skin.
- Suitable humectants include glycerin, lactic acid, pyrrolidone, carbonic acid, urea, polyethylene glycol, polypropylene glycol, sorbitan, PEG-4, and mixtures thereof.
- humectants are water-soluble polymeric humectants and/or hydrogelatinized polysaccharides such as hyaluronic acid, chitosan and/or trehalose-rich polysaccharides obtainable from SOLABIAS, such as Fucogel 1000 (CAS) -Nr. 178463-23-5) 0
- SOLABIAS Fucogel 1000
- Suitable neutralizing agents can also be included in the compositions of the invention, such as emulsifiers, foam buliders and stabilizers.
- Suitable neutralizing agents include alkali metal hydroxides such as sodium hydroxide or potassium hydroxide; organic bases such as diethanolamine, triethanolamine, aminomethylpropanol or mercaptophosphates of these alkanolamines, such as diethanolamine Mercaptophosphate, trisodium ethylenediaminetetraacetate; basic amino acids such as arginine and lysine; and any combination of any of the foregoing.
- the amount of neutralizing agent optionally present is from about 0.01% to about 8% by weight, preferably from about 1% to about 5% by weight based on the total weight of the composition. It is preferred to add an electrolyte to the composition of the invention to modify the properties of the hydrophobic emulsifier.
- the microemulsion of the present invention preferably contains an electrolyte having one or more salts of anions including, but not limited to, hydrochlorides, sulfates, carbonates, borates, and lead salts.
- Other suitable electrolytes may be based on organic anions such as, but not limited to, lactate, acetate, benzoate, propionate, tartrate, and citrate.
- Preferred cations are ammonium ion, guanyl ammonium ion, alkali metal ion, magnesium ion, iron ion and zinc ion.
- Particularly preferred salts are potassium chloride and sodium chloride, magnesium sulfate, zinc sulfate and mixtures thereof.
- the electrolyte is present in an amount of about 0.01% by weight to 48% by weight based on the total weight of the composition.
- composition of the present invention can be used to photoprotect human skin or hair against the damaging effects of ultraviolet radiation, which can be used as a light/sun protection composition or cosmetic.
- These compositions may in particular be lotions, thickening lotions, gels, pastes, Instruction manual
- a milk, ointment, powder or solid tube stick may optionally be packaged as an aerosol and may be provided in the form of a mousse, foam or propellant. They may be in the form of a suspension or dispersion in a solvent or in the form of a fatty substance; or alternatively in the form of an emulsion (preferably a 0/W type such as a cream or a milk, a foaming dispersion), an ointment, a gel, a solid tube Rod or aerosol mousse form.
- the emulsion may also contain anionic, nonionic, cationic or amphoteric surfactants.
- a third aspect of the invention relates to the use of a cosmetic composition for protecting human skin, head, and ultraviolet light.
- the composition may be in the form of shampoo, lotion, gel, that is, before, during or after shampooing, before or after dyeing or bleaching, perm or curling.
- the cosmetic composition of the present invention when used as a cosmetic for eyelashes, eyebrows, skin or hair, such as skin treatment cream, face oil or cream for makeup, lipstick, eye cream, face cream, eyeliner (referred to as 'eye circle') Color liquid), mascara, dyed gel, the cosmetic composition may be in the form of an anhydrous or aqueous solid or paste and such as an oil-in-water or water-in-oil emulsion, suspension or gel.
- a fourth aspect of the invention relates to a method of using the cosmetic composition of the invention to protect the skin and hair from ultraviolet radiation, in particular against sunlight, by a cosmetic composition as defined above or a chemical formula as defined above (The compound is applied to the skin or hair.
- Figure 1 shows the ultraviolet absorption spectrum of the compound (3)
- Figure 2 is an ultraviolet absorption spectrum of the compound (4)
- Reagents p-methoxybenzaldehyde and thionyl chloride (re-distilled before use); malonic acid, L-menthol, pyridine, piperidine, triethylamine, toluene, petroleum ether, etc. are all AR; TLC chromatography Plate, column chromatography silica gel, Qingdao Ocean Chemical Plant.
- Example 1 Instruction manual
- the trans isomer can be partially or completely obtained by high temperature or light, for example, referring to Yang Xiaolong, the conversion of trans-cinnamic acid to cis ⁇ -bromo styrene, Chinese Journal of Pharmaceutical Industry, 2001, 07 .
- 0.1003 g of the compound (1) was weighed, dissolved in absolute ethanol and diluted to 100 ml; 1 ml of the solution was pipetted into a 100 ml volumetric flask; and diluted to the mark to prepare a compound (1) solution having a mass concentration of 10 g/ml.
- Absolute ethanol was used as a blank calibration, and scanned by an ultraviolet-visible spectrophotometer, and scanned in the range of 200 nm to 400 nm.
- the maximum absorption wavelength is 310.50 nm, the absorbance is 1.054, the molar absorption coefficient is 3.36 X 10 4 L/(mol X cm), see Figures 1 and 2; and the maximum absorption wavelength of OMC is 309.50 nm, and the absorbance is 0.461, Molar The absorption coefficient is 1.36 X 10 4 L/(mol X cm), as shown in Figure 3, indicating that compounds 3 and 4 have significantly higher UV absorption than OMC, and cover a wider range of UV wavelengths, which can be used as a potential UVB UV. Use as an absorbent.
- Example 3 Solubility test
- Test solution menthol and compound (3), (4) p-methoxy cinnamic acid menthol ester, respectively, were prepared into a lmg / ml ethanol solution;
- Subjects 10 subjects aged 19-21, 5 males and 5 females;
- Test method Take a small amount of the above two ethanol solutions with absorbent cotton and apply them to the inside of the left and right forearms of the subject respectively to observe the reaction and skin irritation of the subject after use. All subjects were coated with a menthyl ester solution on their left hand and a p-methoxycinnamate menthol ester compound of the formula (3), (4). (3) Test again 2 hours after the test is completed (4).
- Cooling duration 30 minutes, 60 minutes, 120 minutes and 120 minutes.
- Example 5 The above test shows that the compound of the present invention has a mild cooling feeling, a small irritancy, and a long duration of cooling sensation, and is an ideal ultraviolet absorbing agent.
- Example 5 The above test shows that the compound of the present invention has a mild cooling feeling, a small irritancy, and a long duration of cooling sensation, and is an ideal ultraviolet absorbing agent.
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a new UV-B ultraviolet absorbent and a combination containing the UV-B ultraviolet absorbent, especially a partial combination. The combination has good lipid solubility, a strong anti-UV radiation effect, simple formulation and convenient preparation method, and gives cool and comfortable feelings. Meanwhile, the combination has excellent chemical stability. The advantages enable it to be especially suitable for ultraviolet protection for skin and/or hair. Especially, the combination has a strong anti-ultraviolet effect, and has continuous cool and comfortable feature, thereby solving a defect of an existing ultraviolet absorbent.
Description
说 明 书 Description
具有更佳紫外防护效用的紫外吸收剂及其组合物 Ultraviolet absorber with better UV protection effect and composition thereof
技术领域 Technical field
本发明涉及新型 UV-B紫外吸收剂 (防晒剂)并涉及含有上述 UV-B紫外吸收剂的组合物、 特别是局部组合物。 This invention relates to novel UV-B UV absorbers (sunscreens) and to compositions, particularly topical compositions, containing the above UV-B UV absorbers.
发明背景 Background of the invention
根据波长, UV射线被指定为 UV-A射线 (320-400nm)和 UV-B射线 (280-320nm)。 UV射线 对人体皮肤的损伤作用随着波长的降低和暴露持续时间的增加而增加, 因此 UV射线会造成 皮肤损伤, 并且 UV-B辐射可能会造成晒斑 (红斑)直至非常严重的皮肤灼伤。 阳光对皮肤非 常频繁且无保护的照射同样会导致皮肤弹性的损失和皱纹形成的增加,总体来说会导致皮肤 的过早老化, 在极端情况下, 会发生病态皮肤变化至皮肤癌。 UV-A射线可穿入较深的皮肤 层中并且会加速皮肤老化过程,可导致皮肤迅速而微弱地直接形成色素,还会引起皮肤感光 反应或光过敏反应, 在 UV-A照射和增加的皮肤癌危险之间存在着确定的联系。 根据它们的 最大吸收值的位置,用于化妆品和皮肤病制剂的 UV吸收剂分为 UV-A吸收剂和 UV-B吸收剂。 尽管存在大量安全而有效的 UV-B吸收剂, 但是适于保护人体皮肤的 UV-A吸收剂很少, 而 且会受到重大缺陷的影响。 直到今天, 人们已经提出了许多用于皮肤保护 (UV-A和 /或 UV-B) 的化合物。这些化合物中大多数是芳族化合物, 它们可吸收 280-315nm波段, 或 315-400nm 波段, 或整个两种波段中的 UV光线, 它们往往被配制在防晒组合物机中, 这些组合物呈水 包油型乳化液状 (即化妆上可接受的载体由连续分散水相和不连续分散油相组成), 因此它们 含有不同浓度的, 亲脂和 /或亲水的、 能选择性地吸收有害的 UV光线的具有芳族官能的一 种或多种经典有机紫外吸收剂, 这些紫外吸收剂 (及其量)是依据所要求的保护指数进行选择 的 (保护指数 (I P)在数字上是用有 UV紫外吸收剂时达到红斑生成阈值所必需的辐照时间与无 UV紫外吸收剂时达到红斑生成阈值所必需的时间之比表示的)。 Depending on the wavelength, UV rays are designated as UV-A rays (320-400 nm) and UV-B rays (280-320 nm). The damage of UV rays to human skin increases as the wavelength decreases and the duration of exposure increases, so UV rays can cause skin damage, and UV-B radiation can cause sunburn (erythema) to very severe skin burns. Sunlight's very frequent and unprotected exposure to the skin can also result in loss of skin elasticity and increased wrinkle formation, which can lead to premature aging of the skin and, in extreme cases, pathological skin changes to skin cancer. UV-A rays can penetrate deeper into the skin layer and accelerate the skin aging process, which can cause the skin to form pigments quickly and weakly, and also cause skin photosensitivity or photoallergic reactions, in UV-A irradiation and increased There is a definite link between skin cancer risks. UV absorbers for cosmetic and dermatological preparations are classified into UV-A absorbents and UV-B absorbents depending on their position of maximum absorption. Although there are a large number of safe and effective UV-B absorbers, there are few UV-A absorbers suitable for protecting human skin, and they are affected by major defects. To date, many compounds have been proposed for skin protection (UV-A and/or UV-B). Most of these compounds are aromatic compounds that absorb UV light in the 280-315 nm band, or the 315-400 nm band, or the entire two bands, which are often formulated in sunscreen compositions, which are water-based. An oil-in-oil emulsion (ie, a cosmetically acceptable carrier consisting of a continuously dispersed aqueous phase and a discontinuously dispersed oil phase), so that they contain different concentrations, are lipophilic and/or hydrophilic, and selectively absorb harmful UV light of one or more classical organic UV absorbers having an aromatic function, these UV absorbers (and amounts thereof) being selected according to the required protection index (protection index (IP) is used numerically The irradiation time necessary to reach the erythema generation threshold in the UV ultraviolet absorber is expressed as the ratio of the time required to reach the erythema generation threshold when no UV ultraviolet absorber is present.
除了它们的防晒能力之外, 这些具有抗 UV 活性的化合物在含有它们的组合物中还应 该具有良好的化妆性质, 在常见的溶剂中具有良好的溶解度, 尤其在脂肪物质 (如油和脂肪) 中更是如此, 以及具有良好的耐水、 耐汗 (滞留)性质。 在为此目的所推荐的任何芳族化合物 中, 具体地可列举 P-氨基苯甲酸衍生物、亚甲基樟脑衍生物、 肉桂酸衍生物和苯并三唑衍生 物。 然而, 这些物质中的某些物质并不具有在防晒组合物中适合作为 UV紫外吸收剂使用所 要求的任何性质。特别是, 它们固有的防晒能力可能不够, 其按防晒物质使用的各种类型配 方中的溶解度并不总是足够好 (尤其是脂溶解度),它们可能不具有足够的光照稳定性 (光稳定 性), 它们还可能具有较差的耐水和耐汗性。 此外, 人们还希望这些防晒物质不渗透到皮肤 中。 In addition to their ability to protect their sunscreen, these compounds with UV activity should also have good cosmetic properties in compositions containing them, with good solubility in common solvents, especially in fatty materials such as oils and fats. This is especially true, as well as having good water and sweat resistance (stagnation) properties. Among any of the aromatic compounds recommended for this purpose, specifically, a P-aminobenzoic acid derivative, a methylene camphor derivative, a cinnamic acid derivative, and a benzotriazole derivative can be cited. However, some of these materials do not possess any of the properties required for use as a UV absorber in sunscreen compositions. In particular, their inherent sunscreen power may not be sufficient, and the solubility in various types of formulations for sunscreen applications is not always good enough (especially fat solubility), they may not have sufficient light stability (light stability) ), they may also have poor water and sweat resistance. In addition, it is desirable that these sunscreen materials do not penetrate into the skin.
特别是, 无论是 UV-A还是 UV-B防护剂, 或者两者联合的防护剂, 即使其能够发挥较
说 明 书 In particular, whether it is UV-A or UV-B protectant, or a combination of both, even if it can play Description
好的紫外辐射的吸收防护作用,然而,我们知道这些被紫外吸收剂吸收的高能量紫外光并没 有完全消失, 而是将基态的紫外吸收剂转变为其高能态, 部分 /全部处于高能态物质或者通 过释放较低能量的辐射和 /或热量又恢复为基态, 该过程视防护剂的耐光性周而复始, 事实 上, 涂擦紫外吸收剂的人群有很大一部分是较长时间处于较强的日光 /紫外环境中, 虽然紫 外吸收剂能够有效防护高强度紫外辐射造成的皮肤损伤,但是人的皮肤仍然是处于高热的环 境中而极不舒服。针对紫外吸收剂产品的该缺陷, 有部分护肤产品中添加了适量的薄荷, 薄 荷有清凉的作用, 能够在一定程度上缓解皮肤的高热不适的感觉, 然而, 薄荷具有明显的剌 激性的气味和辛辣感, 对皮肤有一定的剌激性, 此外薄荷挥发性强, 作用短暂, 特别是其在 涂布于眼睛附近的皮肤时将对眼睛产生显著的剌激性等缺点。为了克服上述缺点,人们通过 又对薄荷的分子结构进行修饰得到新型清凉剂, 如薄荷醇的酯类、醚类、 薄荷基甲酰胺和薄 荷醇的缩酮类化合物产品,特别是高沸点的薄荷酯类衍生物具有更好的结构稳定性,大大降 低了薄荷醇的挥发性、 易氧化性, 清凉效果温和而持久, 产品几乎无味, 且与许多表面活性 剂配伍性好而在日化用品配方中受到特殊的青睐, 如美国 FDA批准邻氨基苯甲酸薄荷酯可 作为紫外吸收剂。然而这些经过修饰改进的薄荷产品或者紫外防护效果较弱, 需要大量使用 才能起到有效防护的作用,或者作为额外的添加剂加入防护剂产品中导致生产复杂、产品质 量控制的难度加大、 成本增加。 因而, 有必要发现新型既具有期望的理化性质、 强效的抗紫 外效果, 又同时具有持续的、 清凉舒爽特性的化合物。 The absorption protection of good ultraviolet radiation, however, we know that the high-energy ultraviolet light absorbed by the ultraviolet absorber does not completely disappear, but the ground state ultraviolet absorber is converted into a high-energy state, and some/all are in a high-energy state. Or return to the ground state by releasing lower energy radiation and/or heat. This process depends on the lightfastness of the protective agent. In fact, a large part of the people who apply UV absorbers are in a stronger time for a longer period of time. In the ultraviolet environment, although the ultraviolet absorber can effectively protect against skin damage caused by high-intensity ultraviolet radiation, the human skin is still in a high-heat environment and is extremely uncomfortable. For this defect of UV absorber products, some skin care products have added a proper amount of peppermint. Mint has a cooling effect, which can alleviate the feeling of high heat discomfort of the skin to some extent. However, peppermint has a distinct irritating smell. It has a certain stimulating effect on the skin. In addition, the mint has a strong volatility and a short-acting effect, especially when it is applied to the skin near the eyes, it will have significant irritation to the eyes. In order to overcome the above disadvantages, a new type of cooling agent such as an ester of menthol, an ether, a menthyl formamide and a ketal compound of menthol, especially a high-boiling mint, is obtained by modifying the molecular structure of the mint. Ester derivatives have better structural stability, greatly reduce the volatility and oxidizability of menthol, mild and long-lasting cooling effect, almost odorless products, and good compatibility with many surfactants in daily chemical formulations. It is particularly favored, such as the US FDA approval of menthyl anthranilate as an ultraviolet absorber. However, these modified and improved mint products have weak UV protection effects and require a large amount of use to effectively protect them, or as an additional additive to the protective agent product, resulting in complicated production, increased product quality control, and increased cost. . Therefore, it is necessary to find a novel compound which has both desired physical and chemical properties, a strong anti-violet effect, and a continuous, cool and refreshing property.
发明内容 Summary of the invention
本发明第一方面通过提出如下结构的抗紫外吸收作用化合物, 或其顺反异构体或者立 体异构体: The first aspect of the present invention provides an anti-ultraviolet absorption compound, or a cis-trans isomer or a stereoisomer thereof, having the following structure:
式 (1)的化合物优选为其反式异构体, 即具有下列式 (2)的化合物: The compound of the formula (1) is preferably a trans isomer thereof, that is, a compound having the following formula (2):
式 (2)的化合物优选为消旋或者左旋, 即具有下列式 (3)和 (4)的化合物:
The compound of the formula (2) is preferably racemic or left-handed, that is, a compound having the following formulas (3) and (4):
, 解决了上面的不足。 , solved the above deficiencies.
本发明的化合物具有良好的改进性质, 尤其是其良好的脂溶性 (不易被水或汗液侵蚀或 洗脱,而且在产品中可以使用较高浓度而达到极高的或期望的保护指数)、强效的抗 UV辐射 的效果、 具有清凉舒爽的感觉、 简便的配方和便利的制备方法, 同时还具备极好的化学稳定 性 (无论在酸性还是碱性介质中均具有较好的耐水解能力),使其特别适于皮肤和 /或头发的紫 外防护。 The compounds of the invention have good improved properties, especially their good fat solubility (not easily eroded or eluted by water or sweat, and can be used in products with higher concentrations to achieve extremely high or desired protection indices), strong Effective anti-UV radiation effect, cool and refreshing feeling, simple formula and convenient preparation method, as well as excellent chemical stability (good hydrolysis resistance in both acidic and alkaline media) ) making it particularly suitable for UV protection of the skin and/or hair.
本发明的第二方面涉及一种包含式 (1)-(4)紫外吸收剂的化妆组合物。 这种组合物可以是为乳液、 增稠乳液、 乳膏、 凝胶、 溶液、 干粉、 膜剂、 固体棒和气 雾剂。 A second aspect of the invention relates to a cosmetic composition comprising the ultraviolet absorbers of formula (1)-(4). Such compositions may be in the form of emulsions, thickening lotions, creams, gels, solutions, dry powders, films, solid sticks and aerosols.
可以将另外的一种或多种合适的 UV-A和 UV-B紫外吸收剂加入本发明的化妆品和 /或皮 肤病组合物中, 不同的 UV紫外吸收剂组合还可以表现出协同作用。 Additional one or more suitable UV-A and UV-B UV absorbers may be added to the cosmetic and/or skin care compositions of the present invention, and the different UV UV absorber combinations may also exhibit synergistic effects.
UV紫外吸收剂的总量不是关键所在。 合适的量可以为所述组合物总量的 0.5-20wt %, 优选为 0.5-12wt %。 The total amount of UV UV absorber is not critical. A suitable amount may be from 0.5 to 20% by weight, preferably from 0.5 to 12% by weight, based on the total amount of the composition.
可以加入本发明的 UV-A紫外吸收剂中的合适的 UV-B紫外吸收剂为下列有机或无机化 合物: Suitable UV-B UV absorbers which may be added to the UV-A UV absorber of the present invention are the following organic or inorganic compounds:
丙烯酸酯, 例如 2-乙基已基 -2-氰基 -3,3-二苯基丙烯酸酯, 2-氰基 -3,3-二苯基丙烯酸 乙酯等; An acrylate such as 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, 2-cyano-3,3-diphenyl acrylate or the like;
,樟脑衍生物例如 4-甲基亚苄基樟脑、 3-亚苄基樟脑、 樟脑苄垸铵硫酸甲酯、 聚丙烯 酰氨基甲基亚苄基樟脑、 硫代亚苄基樟脑、 硫代甲基亚苄基樟脑、 对苯二叉基樟脑磺酸等; , camphor derivatives such as 4-methylbenzylidene camphor, 3-benzylidene camphor, camphor benzalkonium methyl sulfate, polyacrylamidomethylbenzylidene camphor, thiobenzylidene camphor, thioformate Lysobenzyl camphor, p-phenylidene camphorsulfonic acid, etc.;
•肉桂酸酯衍生物例如甲氧基肉桂酸辛酯、 甲氧基肉桂酸乙氧基乙酯、 甲氧基肉桂酸 二乙醇胺酯、 甲氧基肉桂酸异戊酯等, 以及连接到硅氧垸上的肉桂酸衍生物; • cinnamate derivatives such as octyl methoxycinnamate, ethoxyethyl methoxycinnamate, diethanolamine methoxycinnamate, isoamyl methoxycinnamate, etc., and attached to siloxanes a cinnamic acid derivative;
•对氨基苯甲酸衍生物例如对氨基苯甲酸、 对二甲基氨基苯甲酸 -乙基已酯、 N-氧基 丙烯化的对氨基苯甲酸乙酯、 对氨基苯甲酸甘油酯; • p-aminobenzoic acid derivatives such as p-aminobenzoic acid, p-dimethylaminobenzoic acid-ethylhexyl ester, N-oxyally acrylated ethyl p-aminobenzoate, p-aminobenzoic acid;
•二苯酮例如二苯酮 -3、 二苯酮 -4、 2,2',4,4'-四羟基-二苯酮、 2,2'-二羟基 -4,4-二甲氧基 二苯酮等; • Benzophenones such as benzophenone-3, benzophenone-4, 2,2',4,4'-tetrahydroxy-benzophenone, 2,2'-dihydroxy-4,4-dimethoxy Benzophenone
•亚苄基丙二酸的酯例如 4-甲氧基亚苄基丙二酸二 (2-乙基已基)酯;
说 明 书 • an ester of benzalmalonic acid such as 4-(2-ethylhexyl) 4-methoxybenzylidene malonate; Instruction manual
• 2-(4-乙氧基-苯胺基亚甲基) -丙二酸的酯例如 2-(4-乙氧基-苯胺基亚甲基) -丙二酸二乙 酯; • An ester of 2-(4-ethoxy-anilinomethylidene)-malonic acid such as 2-(4-ethoxy-anilinomethylidene)-malonic acid diethyl ester;
•含有如欧洲专利公开 EP-BI-0358584、 EP-BI-0538431禾 P EP-AI-0709080中描述的亚苄 基丙二酸酯基团的有机硅氧垸化合物; • an organosilicon oxime compound containing a benzalmalonate group as described in European Patent Publication No. EP-BI-0358584, EP-BI-0538431 and P EP-AI-0709080;
•苯并三唑三硅氧垸; • benzotriazole trisiloxane;
•颜料例如微粒状二氧化钛等, 术语 "微粒状"是指约 5nm-约 200nm 的颗粒尺寸, 特别是约 15nm-约 lOOnm , 二氧化钛颗粒也可以涂覆金属氧化物例如氧化铝或氧化锆, 或者 涂覆有机涂料例如多元醇、 甲基硅油、 硬脂酸铝、 垸基硅垸等。 这些涂料是现有技术中公知 的。 • Pigments such as particulate titanium dioxide, etc., the term "particulate" means a particle size of from about 5 nm to about 200 nm, especially from about 15 nm to about 100 nm, and the titanium dioxide particles may also be coated with a metal oxide such as alumina or zirconia, or coated Organic coatings such as polyols, methyl silicone oils, aluminum stearate, decyl silicon germanium, and the like. These coatings are well known in the art.
•咪唑衍生物例如 2-苯基苯并咪唑磺酸及其盐。 2-苯基苯并咪唑磺酸盐, 例如碱金属 盐如钠或钾盐、 铵盐、 吗啉盐、 伯胺盐、 仲胺盐和叔胺盐例如单乙醇胺盐、 二乙醇胺盐等。 • Imidazole derivatives such as 2-phenylbenzimidazolesulfonic acid and salts thereof. The 2-phenyl benzimidazole sulfonate, for example, an alkali metal salt such as a sodium or potassium salt, an ammonium salt, a morpholine salt, a primary amine salt, a secondary amine salt and a tertiary amine salt such as a monoethanolamine salt, a diethanolamine salt or the like.
•水杨酸酯衍生物例如水杨酸异丙基苄酯、 水杨酸苄酯、 水杨酸丁酯、 水杨酸辛酯、 水杨酸异辛酯或水杨酸高孟酯等。 • Salicylate derivatives such as isopropyl benzyl salicylate, benzyl salicylate, butyl salicylate, octyl salicylate, isooctyl salicylate or high maleuryl salicylate.
•三嗪酮衍生物例如辛基三嗪酮、 二辛基丁酰氨基三嗪酮等。 • Triazinone derivatives such as octyltriazinone, dioctylbutyrylaminotriazinone and the like.
可以加入本发明的 UV-A紫外吸收剂中的合适的常规 UV-A紫外吸收剂是下列有机和无 机化合物: Suitable conventional UV-A UV absorbers which may be added to the UV-A UV absorber of the present invention are the following organic and inorganic compounds:
•二苯甲酰甲垸衍生物例如 4-叔丁基 -4'-甲氧基二苯甲酰甲垸、 二甲氧基二苯甲酰基甲 垸、 异丙基二苯甲酰基甲垸等; • Dibenzoylformamidine derivatives such as 4-tert-butyl-4'-methoxydibenzoylformamidine, dimethoxydibenzoylformamidine, isopropyldibenzoylformamidine, etc. ;
•苯并三唑衍生物例如 2,2'-亚甲基-二 (6-(2H-苯并三唑) -2基) -4-(1,1,3,3-四甲基丁基) -苯 酚等; • Benzotriazole derivatives such as 2,2'-methylene-bis(6-(2H-benzotriazol)-2-yl)-4-(1,1,3,3-tetramethylbutyl) ) - phenol, etc.;
•亚苯基 -1,4-二苯并咪唑磺酸或盐例如 2,2-(1,4-亚苯基) -二 -(IH-苯并咪唑 -4,6-二磺酸); • a phenylene-1,4-dibenzimidazole sulfonic acid or salt such as 2,2-(1,4-phenylene)-di-(IH-benzimidazole-4,6-disulfonic acid);
•氨基取代的羟基二苯酮例如如欧洲专利公开 EP1046391中描述的 2-(4二乙基氨基 -2- 羟基-苯甲酰基)—苯甲酸乙酯; An amino-substituted hydroxybenzophenone such as 2-(4diethylamino-2-hydroxy-benzoyl)-benzoic acid ethyl ester as described in European Patent Publication EP1046391;
•颜料例如微粒状氧化锌等。 术语 "微粒状"是指约 5nm-约 200nm 的颗粒尺寸, 特 别是约 15nm-约 lOOnm , 二氧化钛颗粒也可以涂覆金属氧化物例如氧化铝或氧化锆,或者涂 覆有机涂料例如多元醇、 甲基硅油、硬脂酸铝、垸基硅垸等。这些涂料是现有技术中公知的。 • Pigments such as particulate zinc oxide. The term "particulate" means a particle size of from about 5 nm to about 200 nm, especially from about 15 nm to about 100 nm, and the titanium dioxide particles may also be coated with a metal oxide such as alumina or zirconia, or coated with an organic coating such as a polyol, A Base silicone oil, aluminum stearate, fluorenyl silicon germanium, and the like. These coatings are well known in the art.
由于二苯甲酰基甲垸衍生物是光不稳定的 UV-A紫外吸收剂, 理想的是使其光稳定化。 本发明的组合物还可以含有常用的化妆品助剂和添加剂, 例如防腐剂 /抗氧化剂、 脂肪 物质 /油、 水、 有机溶剂、 聚硅氧垸、 增稠剂、 软化剂、 乳化剂、 消泡剂、 保湿剂、 香料、 表面活性剂、 填料、 鳌合剂、 阴离子聚合物、 阳离子聚合物、 非离子聚合物或两性聚合物或 其混合物、 推进剂、 酸化剂或碱化剂、 染料、 着色剂、 颜料或纳米颜料, 特别是适于通过物 理遮蔽紫外辐射提供附加光保护作用的那些,或者通常配入化妆品的任何其他成分,特别是
说 明 书 Since the dibenzoylformamidine derivative is a photolabile UV-A ultraviolet absorber, it is desirable to stabilize the light. The compositions of the present invention may also contain conventional cosmetic auxiliaries and additives such as preservatives/antioxidants, fatty substances/oils, water, organic solvents, silicones, thickeners, softeners, emulsifiers, defoaming agents. Agent, humectant, perfume, surfactant, filler, chelating agent, anionic polymer, cationic polymer, nonionic polymer or amphoteric polymer or mixture thereof, propellant, acidifier or alkalizing agent, dye, colorant , pigments or nanopigments, especially those suitable for providing additional photoprotection by physical shielding of ultraviolet radiation, or any other ingredient usually formulated with cosmetics, especially Description
用于制备防晒 /机光组合物的那些。 Those used to prepare sunscreen/communication compositions.
技术人员可以容易地根据所需制品而选择化妆品和皮肤病用助剂和添加剂的必要量。 特别优选的抗氧化剂是选自以下物质的那些: 氨基酸 (例上甘氨酸、 组氨酸、 酪氨酸、 色氨酸)和它们的衍生物; 肽类, 例如 DL-肌肽、 D-肌肽、 L-肌肽和衍生物 (例如鹅肌肽); 类 胡萝卜素、 胡萝卜素 (例如 P-胡萝卜素、 Y-胡萝卜素、 番茄红素)和衍生物; 绿原酸和衍生物; 脂酮酸和衍生物 (例如二氢脂酮酸);硫化葡萄糖金、丙基硫尿嘧啶和其他硫醇 (例如谷胱甘肽、 半胱氨酸、 胱氨酸、 胱氨和其糖基-、 N-乙酰基-、 甲基-、 乙基-、 丙基-、 戊基-、 丁基 -和月 桂基-、 棕榈酸基-、 油基-、 Y-亚油基-、 胆固醇基和甘油基酯)和其盐; 二月桂基硫代二丙酸 酯、 二硬脂基硫代二丙酸酯、 硫代二丙酸和其衍生物 (酯、 醚、 肽、 脂质、 核苷酸、 核苷和 盐类)以及非常低的相容剂量 (例如从 p mol- μ mol/kg)的亚砜胺化合物 (例如丁硫氨酸亚砜胺、 高半脱氨酸亚砜胺); 额外的 (金属)鳌合剂 (例如-羟基脂肪酸、 棕榈酸、 肌醇六磷酸、 乳铁蛋 白); a-羟基酸 (例如柠檬酸、 乳酸、 苹果酸)、 没食子酸、 没食子提取物、 胆红素、 胆绿素、 EDTA、 EGTA和其衍生物; 不饱和脂肪酸和其衍生物 (例如 Y-亚油酸、 亚油酸、 油酸); 叶酸和 其衍生物; 泛醌和泛醇以及它们的衍生物; 维生素 C和其衍生物, 例如醋酸抗坏血酸酯; 生 育酚和衍生物 (例如维生素 E醋酸酯); 维生素 A和衍生物 (维生素 A棕榈酯)以及松柏基苯甲 酸酯、 芸香亭酸和衍生物、 a-糖基芸香苷、 阿魏酸、 亚糠基葡糖醇、 肌肽、 丁羟基甲苯、 丁 羟基茴香醚、 三羟基丙基苯基酮、 硒和衍生物 (例如硒甲硫氨酸)。 The skilled person can easily select the necessary amount of cosmetic and dermatological auxiliaries and additives depending on the desired product. Particularly preferred antioxidants are those selected from the group consisting of amino acids (eg, glycine, histidine, tyrosine, tryptophan) and derivatives thereof; peptides such as DL-carnosine, D-carnosine, L - carnosine and derivatives (eg goose carnosine); carotenoids, carotenes (eg P-carotene, Y-carotene, lycopene) and derivatives; chlorogenic acids and derivatives; fatty acides and derivatives (eg dihydroaliphatic acid); glucosinolate, propylthiouracil and other thiols (eg glutathione, cysteine, cystine, cystine and its glycosyl-, N-acetyl) -, methyl-, ethyl-, propyl-, pentyl-, butyl- and lauryl-, palmitic acid-, oleyl-, Y-linoleyl-, cholesteryl and glyceryl esters and a salt thereof; dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and Salts) and very low compatible doses (eg from p mol-μ mol/kg) of sulfoxide amine compounds (eg butyl sulfoxide sulfoxide amine, high semi-dead) Acid sulfoxide amine; additional (metal) chelating agents (eg -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin); a-hydroxy acids (eg citric acid, lactic acid, malic acid), gallic acid, Gallop extract, bilirubin, biliverdin, EDTA, EGTA and its derivatives; unsaturated fatty acids and their derivatives (eg Y-linoleic acid, linoleic acid, oleic acid); folic acid and its derivatives; pan Bismuth and panthenol and their derivatives; vitamin C and its derivatives, such as ascorbyl acetate; tocopherols and derivatives (such as vitamin E acetate); vitamin A and derivatives (vitamin A palmitate) and coniferyl benzene Formate, musk acid and derivatives, a-glycosyl rutin, ferulic acid, decyl glucosamine, carnosine, butylated hydroxytoluene, butylated hydroxy anisole, trihydroxypropyl phenyl ketone, selenium and Derivatives (eg selenium methionine).
防腐剂和 /或抗氧化剂可以存在的量为所述组合物总重量的约 0.01-约 10wt%, 优选地, 防腐剂和 /或抗氧化剂存在的量为约 0.1-约 lwt %。 The preservative and/or antioxidant may be present in an amount of from about 0.01% to about 10% by weight based on the total weight of the composition. Preferably, the preservative and/or antioxidant are present in an amount from about 0.1% to about 1% by weight.
根据本发明的组合物还可以含有乳化剂, 乳化剂可以使两种或更多种不可混溶的液体 均匀混合, 同时提高该组合物的粘度。 此外, 乳化剂起到稳定所述组合物的作用。 The composition according to the present invention may further contain an emulsifier which can uniformly mix two or more immiscible liquids while increasing the viscosity of the composition. In addition, the emulsifier acts to stabilize the composition.
可以根据本发明使用的形成 0/W、 W/O和 /或 0/W/0型制剂的乳化剂包括油酸失水山 梨糖醇酯、 倍半油酸失水山梨糖醇酯、 异硬脂酸失水山梨糖醇酯、 三油酸失水山梨糖醇酯、 聚甘油基-二异硬脂酸酯、 油酸异硬脂酸的聚甘油酯、 聚甘油基 -6-六蓖麻油酸酯、 聚甘油基 -4-油酸酯、 聚甘油基 -4-油酸酯 /PEG-8丙二醇椰酸酯、 油酰胺 DEA、 TEA肉豆蔻酸酯、 TEA硬 脂酸酯、 硬脂酸镁、 硬脂酸钠、 月桂酸钾、 蓖麻油酸钾、 椰酸钠、 牛油酸钠、 海狸香酸钾、 油酸钠和其混合物。 其他合适的乳化剂是磷酸酯和其盐, 例如磷酸鲸蜡基酯、 DEA磷酸鲸蜡 基酯、 磷酸十六垸基酯钾盐、 油酸甘油酯磷酸钠、 氢化的植物甘油酯磷酸盐和其混合物。此 外, 一种或多种合成聚合物可以用作乳化剂, 例如, PVP 二十碳烯共聚物、 丙烯酸酯 /丙烯 酸 C10-C30垸基酯交叉聚合物、 丙烯酸酯 /甲基丙烯酸硬脂基酯共聚物、 PEG-2?/十二垸基二 醇共聚物、 PEG-4 十二垸基二醇共聚物和其混合物。 优选的乳化剂是 PVP二十碳烯共聚物、 丙烯酸酯 /丙烯酸 C10-C30垸基酯交叉聚合物、 PEG-20失水山梨糖醇异硬脂酸酯、 异硬脂酸 失水山梨糖醇酯和其混合物。 Emulsifiers which can be used in accordance with the invention to form 0/W, W/O and/or 0/W/0 formulations include sorbitan oleate, sorbitan sesquioleate, iso-hard Sorbitan acid sorbitan ester, sorbitan trioleate, polyglyceryl-diisostearate, polyglycerol ester of oleic acid isostearic acid, polyglyceryl-6-hexaparale Acid ester, polyglyceryl-4-oleate, polyglyceryl-4-oleate/PEG-8 propylene glycol cocoate, oleamide DEA, TEA myristate, TEA stearate, stearic acid Magnesium, sodium stearate, potassium laurate, potassium ricinoleate, sodium covate, sodium tauroate, potassium betulinate, sodium oleate and mixtures thereof. Other suitable emulsifiers are phosphates and salts thereof, such as cetyl phosphate, DEA cetyl phosphate, potassium hexadecanoate, sodium oleate, hydrogenated plant glyceride phosphates and Its mixture. In addition, one or more synthetic polymers can be used as emulsifiers, for example, PVP eicosene copolymer, acrylate/acrylic acid C10-C30 decyl ester crosspolymer, acrylate/stearyl methacrylate Copolymer, PEG-2?/dodecyl glycol copolymer, PEG-4 dodecyl glycol copolymer and mixtures thereof. Preferred emulsifiers are PVP eicosene copolymer, acrylate/C10-C30 decyl crosspolymer, PEG-20 sorbitan isostearate, sorbitan isostearate Esters and mixtures thereof.
乳化剂存在的总量为所述组合物总重量的约 0.01wt%4 15wt%, 优选约 0.1 ^%-约 3wt%。
说 明 书 The emulsifier is present in a total amount of from about 0.01% by weight to about 45% by weight, preferably from about 0.1% to about 3% by weight based on the total weight of the composition. Instruction manual
脂肪 /油相有利地选自: The fat/oil phase is advantageously selected from:
•矿物油和矿物蜡; • mineral oil and mineral wax;
,油, 例如癸酸或辛酸的三甘油酯, 优选蓖麻油; , oil, such as triglyceride of citric acid or octanoic acid, preferably castor oil;
,天然或合成油, 优选碳酸或脂肪酸与醇例如异丙醇、 丙二醇或甘油的酯; •苯甲酸垸基酯; a natural or synthetic oil, preferably an ester of carbonic acid or a fatty acid with an alcohol such as isopropanol, propylene glycol or glycerol; • a decyl benzoate;
•聚硅氧垸例如二甲基聚硅氧垸、 二已基聚硅氧垸、 二苯基聚硅氧垸和其混合物。 可以加入本发明组合物的油相的脂肪物质有利地选自: 具有 3-30个碳原子的饱和和 / 或不饱和的直链或支链烃基酸与具有 3-30个碳原子的饱和和 /或不饱和的直链和 /或支链醇 的酯, 以及芳族酸和具有 3-30个碳原子的饱和和 /或不饱和的直链或支链醇的酯。 这些酯可 以有利地选自: 新戊酸异硬脂基酯、 单硬脂酸二甘醇酯、 对羟基苯甲酸异丁基酯、 丙烯酸酯 C10-C30垸基丙烯酸酯、 棕榈酸辛酯、 椰油酸辛酯、 椰油酸癸酯、 异硬脂酸辛酯、 肉豆蔻酸 辛基十二垸基酯、 异壬酸鲸蜡基酯、 肉豆蔻酸异丙酯、 棕榈酸异丙酯、 硬脂酸异丙酯、 油酸 异丙酯、 硬脂酸正丁酯、 月桂酸正己酯、 油酸正癸酯、 硬脂酸异辛酯、 硬脂酸异壬酯、 异壬 酸异壬酯、 棕搁酸 2-乙基己酯、 月桂酸 2-乙基己酯、 硬脂酸 2-己基癸酯、 棕榈酸 2-辛基十 二垸基酯、 庚酸硬脂基酯、 油酸油基酯、 芥酸油基酯、 油酸瓢菜心基酯、 芥酸瓢菜心基酯、 硬脂酸三癸酯、偏苯三酸三癸酯, 以及选自这些酯的合成混合物、 半合成混合物和天然混合 物例如霍霍巴油。 • Polysiloxanes such as dimethylpolysiloxane, dihexylpolysiloxane, diphenylpolysiloxane and mixtures thereof. The fatty substance which may be added to the oil phase of the composition of the invention is advantageously selected from the group consisting of saturated and/or unsaturated linear or branched hydrocarbyl acids having from 3 to 30 carbon atoms and saturated with from 3 to 30 carbon atoms. An ester of an unsaturated linear and/or branched alcohol, and an ester of an aromatic acid and a saturated and/or unsaturated linear or branched alcohol having from 3 to 30 carbon atoms. These esters may advantageously be selected from the group consisting of: isostearyl neopentanoate, diethylene glycol monostearate, isobutyl p-hydroxybenzoate, acrylate C10-C30 mercapto acrylate, octyl palmitate, coconut Octyl oleate, decyl cocoate, octyl isostearate, octyldodecanyl myristate, cetyl isononate, isopropyl myristate, isopropyl palmitate, stearic acid Isopropyl ester, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isodecyl stearate, isodecyl isononanoate, brown 2-ethylhexyl acid release, 2-ethylhexyl laurate, 2-hexyl decyl stearate, 2-octyldodecanyl palmitate, stearyl heptanoate, oleic acid base Esters, oleic acid oleyl esters, oleic acid heart starch esters, erucic acid lysine core esters, tridecyl stearate, tridecyl trimellitate, and synthetic mixtures selected from these esters, semi-synthetic Mixtures and natural mixtures such as jojoba oil.
适用于本发明组合物的其他脂肪组分包括极性油例如卵磷脂和脂肪酸三甘油酯, 即 8-24个碳原子、 优选 12-18个碳原子的饱和和 /或不饱和的直链或支链合碳酸的三甘油酯, 然而脂肪酸三甘油酯优选选自合成油、 半合成油和天然油 (例如椰油甘油酯、 橄榄油、 向日 葵油、 豆油、 花生油、 菜油、 杏仁油、 棕榈油、 椰子油、 蓖麻油、 氢化蓖麻油、 麦油、 葡萄 油和其他油); 非极性油例如线型和 /或支链径和蜡, 例如矿物油、 凡士林 (矿脂); 石蜡、 角 鲨垸和角鲨烯、 聚烯烃 (有利的是聚癸烯)、 氢化的聚异丁烯和异十六垸; 二垸基酸例如二辛 酰基醚; 线型或环状硅油例如环甲基硅油、 八甲基环状四聚硅氧垸、 十六垸基二甲硅油、 六 甲基环三硅氧院、 聚二甲基硅氧垸、 聚 (甲基苯基硅氧垸)和其混合物。 可以有利地加入本发明组合物中的其他脂肪组分是异二十垸; 二庚酸新戊二醇酯; 二 辛酸 /二癸酸丙二醇酯; 琥珀酸辛酯 /癸酯 /二甘油酯; 辛酸 /癸酸丁二醇酯; 乳酸 C12-13垸基 酯; 酒石酸二 C12-13垸基酯; 异甘油三硬脂酸酯; 六辛酸 /六癸酸二季戊四醇酯; 单异硬脂 酸丙二醇酯; 甘油三辛酸酯; 异山梨酸二甲酯。 特别优选使用苯甲酸 C12-15垸基酯和异硬 脂酸 2-乙基己酯的混合物、 苯甲酸 C12-15 垸基酯和异壬酸异三癸酯的混合物以及苯甲酸 C12-15垸基酯、 异硬脂酸 2-乙基己酯和异壬酸异三癸酯的混合物。 本发明组合物的油相还可以含有天然植物蜡或动物蜡例如蜂蜡、 中国蜡、 大黄蜂蜡和 其他昆虫蜡以及牛油树脂。 Other fatty components suitable for use in the compositions of the present invention include polar oils such as lecithin and fatty acid triglycerides, i.e., saturated and/or unsaturated straight chains of 8 to 24 carbon atoms, preferably 12 to 18 carbon atoms. Branched carbonic acid triglyceride, however fatty acid triglyceride is preferably selected from the group consisting of synthetic oils, semi-synthetic oils and natural oils (eg cocoglycerides, olive oil, sunflower oil, soybean oil, peanut oil, vegetable oil, almond oil, palm oil) , coconut oil, castor oil, hydrogenated castor oil, wheat oil, grape oil and other oils); non-polar oils such as linear and / or branched diameter and wax, such as mineral oil, petrolatum (petrolatum); paraffin, horn Shark and squalene, polyolefin (favorable polydecene), hydrogenated polyisobutylene and isohexadecane; dimercapto acid such as dioctanoyl ether; linear or cyclic silicone oil such as cyclomethicone, Octamethylcyclotetrasiloxane, hexadecanyl dimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane) and mixtures thereof. Other fatty components which may be advantageously added to the compositions of the invention are isodecahedon; neopentyl glycol heptanoate; propylene glycol diacrylate/dicaprate; octyl succinate/decyl acrylate/diglyceride; octanoic acid /butylene citrate; C12-13 decyl lactate; di C12-13 decyl tartrate; isoglyceryl tristearate; hexacyanoic acid / dipentaerythritol hexarate; propylene glycol monoisostearate ; Trioctyl glycerate; Dimethyl isosorbate. Particular preference is given to using a mixture of C12-15 decyl benzoate and 2-ethylhexyl isostearate, a mixture of C12-15 decyl benzoate and isodecyl isononanoate and C12-15 benzoic acid. A mixture of a base ester, 2-ethylhexyl isostearate and isodecyl isononanoate. The oil phase of the compositions of the present invention may also contain natural vegetable waxes or animal waxes such as beeswax, Chinese wax, rhubarb and other insect waxes, and shea butter.
本发明组合物可以另外含有一种或多种润肤剂。 润肤剂为皮肤表面提供软化或平滑作
说 明 书 The compositions of the present invention may additionally contain one or more emollients. An emollient that softens or smoothes the surface of the skin Description
用并且通常被认为就局部使用而言是安全的。润肤剂也有助于控制蒸发速率和所述组合物的 粘性。 优选的润肤剂包括矿物油、 羊毛脂油、 椰子油、 可可脂、 橄榄油、 芦荟提取物、 霍霍 巴油、 蓖麻油、 脂肪酸例如油酸和硬脂酸、 脂肪醇例如鲸蜡醇或十六垸基醇、 己二酸二异丙 基酯、 C9-C15醇的苯甲酸酯和羟基苯甲酸酯、 异壬酸异壬酯、 C15-C50垸烃、 矿物油、 硅氧 垸例如二甲基聚硅氧垸、 醚例如聚氧化丙烯丁醚和聚氧化丙烯鲸蜡基醚, 和苯甲酸 C2-C15 垸基酯及其混合物。 最优选的润肤剂是羟基苯甲酸酯、 芦荟、 苯甲酸 C12-C15垸基酯及其混 合物。 Used and generally considered safe for topical use. The emollient also helps to control the rate of evaporation and the viscosity of the composition. Preferred emollients include mineral oil, lanolin oil, coconut oil, cocoa butter, olive oil, aloe extract, jojoba oil, castor oil, fatty acids such as oleic acid and stearic acid, fatty alcohols such as cetyl alcohol or sixteen Mercapto alcohol, diisopropyl adipate, benzoate and hydroxybenzoate of C9-C15 alcohol, isodecyl isononanoate, C15-C50 anthraquinone, mineral oil, siloxane such as Methyl polysiloxane, ethers such as polyoxypropylene butyl ether and polyoxypropylene cetyl ether, and C2-C15 decyl benzoate and mixtures thereof. The most preferred emollients are hydroxybenzoate, aloe vera, C12-C15 decyl benzoate and mixtures thereof.
润肤剂存在的量为所述组合物总重量的约 1\^ %-约 20Wt %,优选约 2 ^ %-约 15wt %, 最优选约 4wt% -约 10wt %。 本发明制剂的水相可以含有常用的化妆品添加剂例如醇, 尤其是低级醇, 优选乙醇和 / 或异丙醇、 低级垸基二醇或多元醇及其醚, 优选丙二醇、 丙三醇、 乙二醇、 乙二醇单乙醚或 乙二醇单丁醚、 丙二醇单甲醚、 丙二醇单乙醚或丙二醇单丁醚、 二甘醇单甲醚或单乙醚和类 似制品、 聚合物、 泡沫稳定剂; 电解质和尤其是一种或多种增稠剂。 The emollient is present in an amount from about 1% to about 20% by weight based on the total weight of the composition, preferably from about 2% to about 15% by weight, most preferably from about 4% to about 10% by weight. The aqueous phase of the preparation of the invention may contain customary cosmetic additives such as alcohols, especially lower alcohols, preferably ethanol and/or isopropanol, lower mercapto diols or polyols and ethers thereof, preferably propylene glycol, glycerol, ethylene Alcohol, ethylene glycol monoethyl ether or ethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether or propylene glycol monobutyl ether, diethylene glycol monomethyl ether or monoethyl ether and similar products, polymer, foam stabilizer; electrolyte And especially one or more thickeners.
可以用于本发明制剂的增稠剂包括二氧化硅类、 硅酸镁和 /或硅酸铝类、 多糖和其衍生 物例如透明质酸、 黄原胶、 羟丙基纤维素、 丙烯酸酯共聚物, 优选卡波姆类的聚丙烯酸酯例 如 980、 981、 1382、 2984、 5984型卡波姆。 Thickeners which can be used in the formulations of the present invention include silicas, magnesium silicates and/or aluminum silicates, polysaccharides and derivatives thereof such as hyaluronic acid, xanthan gum, hydroxypropyl cellulose, acrylate copolymers. Preferred are carbomer polyacrylates such as carbomers of the 980, 981, 1382, 2984, 5984 type.
保湿剂, 例如湿润剂可以加入本发明的组合物中以减少皮肤角质层的经皮失水 (TEWL)。 合适的湿润剂包括甘油、 乳酸、 吡咯垸酮、碳酸、 脲、 聚乙二醇、 聚丙二醇、 失水山梨糖醇、 PEG-4和其混合物。另外合适的保湿剂是水溶型聚合物保湿剂和 /或遇水凝胶化的多糖例如透 明质酸、 壳聚糖和 /或可从 SOLABIAS 获得的富含海藻糖的多糖, 例如 Fucogel 1000(CAS-Nr. 178463-23-5) 0 任选存在的保湿剂的量为所述组合物总重量的约 0.5\^ % -约 8wt %, 优选约 lWt % -约 5 Wt %。 合适的中和剂也可以包含在本发明组合物中, 例如乳化剂、 泡沫清洁剂 (foam bulider) 和稳定剂。合适的中和剂包括碱金属氢氧化物, 例如氢氧化钠或氢氧化钾; 有机碱例如二乙 醇胺、三乙醇胺、氨基甲基丙醇或者这些醇胺的垸基磷酸酯,例如二乙醇胺十六垸基磷酸酯, 亚乙基二胺四乙酸三钠; 碱性氨基酸例如精氨酸和赖氨酸; 以及上述任何物质的任意组合。 任选存在的中和剂的量为所述组合物总重量的约 0.01wt%-8wt %, 优选约 1 ^ %-约 5Wt %。 优选向本发明组合物中加入电解质以改变疏水型乳化剂的性能。 因此, 本发明的微乳 液优选含有具有阴离子的一种或几种盐的电解质, 所述盐包括但不限于盐酸盐、硫酸盐、碳 酸盐、 硼酸盐和铅酸盐。 其他合适的电解质可以基于有机阴离子, 例如但不限于乳酸盐、 醋 酸盐、 苯甲酸盐、 丙酸盐、 酒石酸盐和柠檬酸盐。 优选的阳离子是铵离子、 垸基铵离子、 碱 金属离子、 镁离子、 铁离子和锌离子。 特别优选的盐是氯化钾和氯化钠、 硫酸镁、 硫酸锌和 其混合物。 电解质存在的量为所述组合物总重量的约 0.01wt%4 8wt %。 A humectant, such as a humectant, can be added to the compositions of the present invention to reduce transepidermal water loss (TEWL) in the stratum corneum of the skin. Suitable humectants include glycerin, lactic acid, pyrrolidone, carbonic acid, urea, polyethylene glycol, polypropylene glycol, sorbitan, PEG-4, and mixtures thereof. Further suitable humectants are water-soluble polymeric humectants and/or hydrogelatinized polysaccharides such as hyaluronic acid, chitosan and/or trehalose-rich polysaccharides obtainable from SOLABIAS, such as Fucogel 1000 (CAS) -Nr. 178463-23-5) 0 The amount of humectant optionally present is from about 0.5% to about 8% by weight, preferably from about 1% by weight to about 5% by weight based on the total weight of the composition. Suitable neutralizing agents can also be included in the compositions of the invention, such as emulsifiers, foam buliders and stabilizers. Suitable neutralizing agents include alkali metal hydroxides such as sodium hydroxide or potassium hydroxide; organic bases such as diethanolamine, triethanolamine, aminomethylpropanol or mercaptophosphates of these alkanolamines, such as diethanolamine Mercaptophosphate, trisodium ethylenediaminetetraacetate; basic amino acids such as arginine and lysine; and any combination of any of the foregoing. The amount of neutralizing agent optionally present is from about 0.01% to about 8% by weight, preferably from about 1% to about 5% by weight based on the total weight of the composition. It is preferred to add an electrolyte to the composition of the invention to modify the properties of the hydrophobic emulsifier. Accordingly, the microemulsion of the present invention preferably contains an electrolyte having one or more salts of anions including, but not limited to, hydrochlorides, sulfates, carbonates, borates, and lead salts. Other suitable electrolytes may be based on organic anions such as, but not limited to, lactate, acetate, benzoate, propionate, tartrate, and citrate. Preferred cations are ammonium ion, guanyl ammonium ion, alkali metal ion, magnesium ion, iron ion and zinc ion. Particularly preferred salts are potassium chloride and sodium chloride, magnesium sulfate, zinc sulfate and mixtures thereof. The electrolyte is present in an amount of about 0.01% by weight to 48% by weight based on the total weight of the composition.
本发明组合物可用于对人体表皮或毛发进行光保护以防紫外辐射的损伤作用, 其可以 作为抗光 /防晒组合物或化妆品。 这些组合物可以特别地以洗液、 增稠洗液、 凝胶、 膏状物、
说 明 书 The composition of the present invention can be used to photoprotect human skin or hair against the damaging effects of ultraviolet radiation, which can be used as a light/sun protection composition or cosmetic. These compositions may in particular be lotions, thickening lotions, gels, pastes, Instruction manual
乳状物、软膏、粉末或固体管棒的形式提供,并可以任选地包装成气溶胶, 以及可以以摩丝、 泡沫或喷射剂形式提供。它们可以呈溶剂中的悬浮液或分散液形式或者脂肪物质形式; 或者 作为选择地乳液形式 (优选 0/W型例如膏状物或乳状物、 起泡分散体)、 软膏、 凝胶、 固体管 棒或者气溶胶摩丝形式。 该乳液还可以含有阴离子、 非离子、 阳离子或两性表面活性剂。 It is provided in the form of a milk, ointment, powder or solid tube stick and may optionally be packaged as an aerosol and may be provided in the form of a mousse, foam or propellant. They may be in the form of a suspension or dispersion in a solvent or in the form of a fatty substance; or alternatively in the form of an emulsion (preferably a 0/W type such as a cream or a milk, a foaming dispersion), an ointment, a gel, a solid tube Rod or aerosol mousse form. The emulsion may also contain anionic, nonionic, cationic or amphoteric surfactants.
本发明的第三方面涉及化妆组合物在保护人的皮肤、 头, 防紫外线上的应用。 A third aspect of the invention relates to the use of a cosmetic composition for protecting human skin, head, and ultraviolet light.
当本发明化妆组合物用于保护头发时, 该组合物可呈香波、 洗液、 凝胶状, 即洗发前 后、 染色或脱色前后、 烫发或者卷发异直之前、 之中或之后清洗、 涂敷的组合物, 梳理或处 理洗液或凝胶,梳整或将头发作成波浪状的洗液或凝胶、发浆、烫发或将卷发弄直的组合物, 头发染色或脱色组合物状。 When the cosmetic composition of the present invention is used for protecting hair, the composition may be in the form of shampoo, lotion, gel, that is, before, during or after shampooing, before or after dyeing or bleaching, perm or curling. A composition for application, combing or treating a lotion or gel, combing or wavy a lotion or gel, hair styling, perming or straightening the hair, hair dyeing or discoloring composition.
当本发明化妆组合物用作睫毛、 眉毛、 皮肤或头发化妆品时, 如皮肤处理膏、 化妆时 打底的面油或面霜、 口红、 眼膏、 面膏、 眼线膏 (称之 '描眼圈"的彩色液)、 睫毛油、 染色凝 胶、该化妆组合物可以呈无水或含水的固体或糊状和如水包油或油包水乳化液、悬浮液或凝 胶。 When the cosmetic composition of the present invention is used as a cosmetic for eyelashes, eyebrows, skin or hair, such as skin treatment cream, face oil or cream for makeup, lipstick, eye cream, face cream, eyeliner (referred to as 'eye circle') Color liquid), mascara, dyed gel, the cosmetic composition may be in the form of an anhydrous or aqueous solid or paste and such as an oil-in-water or water-in-oil emulsion, suspension or gel.
本发明的第四方面涉及一种使用本发明的化妆组合物保护皮肤和头发防紫外线照射, 尤其是防太阳光照射的方法, 该方法在于将上面限定的化妆组合物或如前面定义的化学式 (工)化合物涂敷到皮肤或头发上。 A fourth aspect of the invention relates to a method of using the cosmetic composition of the invention to protect the skin and hair from ultraviolet radiation, in particular against sunlight, by a cosmetic composition as defined above or a chemical formula as defined above ( The compound is applied to the skin or hair.
具体实施方式 detailed description
下面的实施例对本发明作了说明而又不限制其范围: 附图说明 The following examples illustrate the invention without limiting its scope:
附图 1 化合物 (3)的紫外吸收光谱; Figure 1 shows the ultraviolet absorption spectrum of the compound (3);
附图 2 化合物 (4)的紫外吸收光谱; Figure 2 is an ultraviolet absorption spectrum of the compound (4);
附图 3 OMC的紫外吸收光谱 Figure 3 UV absorption spectrum of OMC
实施例 Example
仪器与试剂 Instruments and reagents
仪器: 400M傅里叶变换核磁共振波谱仪 (德国 bmker公司), CDCI3为溶剂 ,TMS为内标; 离子肼质谱仪 (德国 bmker 公司); UV-3100PC 紫外-可见分光光度计 (上海 Mapada 公司); Instrument: 400M Fourier transform NMR spectrometer (Bmker, Germany), CDCI3 as solvent, TMS as internal standard; Ion 肼 mass spectrometer (Bmker, Germany); UV-3100PC UV-visible spectrophotometer (Shanghai Mapada) ;
WRS-1A数字熔点仪 (上海索光光电技术有限公司)。 WRS-1A Digital Melting Point Instrument (Shanghai Suoguang Optoelectronic Technology Co., Ltd.).
试剂: 对甲氧基苯甲醛和二氯亚砜 (使用前重蒸); 丙二酸、 L-薄荷醇、 吡啶、 哌啶、 三 乙胺、 甲苯、 石油醚等均为 AR; TLC层析板, 柱层析用硅胶, 青岛海洋化工厂。 实施例 1
说 明 书 Reagents: p-methoxybenzaldehyde and thionyl chloride (re-distilled before use); malonic acid, L-menthol, pyridine, piperidine, triethylamine, toluene, petroleum ether, etc. are all AR; TLC chromatography Plate, column chromatography silica gel, Qingdao Ocean Chemical Plant. Example 1 Instruction manual
该实施阐明了制备具有式 (1)-(4)的本发明化合物的通用方法: This example illustrates a general method for preparing compounds of the invention having formulas (1)-(4):
1.1对甲氧基肉桂酸的合成 Synthesis of 1.1 p-methoxycinnamic acid
在装有温度计和回流冷凝管的三颈瓶中, 依次加入对甲氧基苯甲醛 (13.60g, O.lOmol), 丙二酸 (14.60g, 0.14mol), 吡啶 (7.90g, O.lOmol), 哌啶 (0.08g, lmmol), 搅拌、 85°C反应 6h。 冷却至室温, 搅拌下加入冷水 (80ml), 析出固体, 抽滤, 冷水洗涤两次, 干燥, 乙醇重结晶 得反式目标化合物 14.49g, 产率 87.8%, 熔点为 172〜174°C (173〜175°C, 参见卢莲英等, 防晒剂对甲氧基肉桂酸异辛酯的合成, 化学世界, 2006,11:672-675: )。 In a three-necked flask equipped with a thermometer and a reflux condenser, p-methoxybenzaldehyde (13.60 g, 0.1 mol), malonic acid (14.60 g, 0.14 mol), pyridine (7.90 g, O.10 mol) were sequentially added. Piperidine (0.08 g, 1 mmol), stirred, and reacted at 85 ° C for 6 h. After cooling to room temperature, cold water (80 ml) was added under stirring, and the solid was precipitated, suction filtered, washed twice with cold water, dried, and recrystallized from ethanol to give the title compound 14.49 g, yield 87.8%, melting point 172 174. ~175 ° C, see Lu Lianying et al, the synthesis of sunscreen octyl methoxycinnamate, Chemical World, 2006, 11: 672-675: ).
将反式异构体通过高温或者光照可以部分或全部得到顺式产物, 例如, 参照杨小龙, 取代反式肉桂酸转化为顺式 β _溴代苯乙烯, 中国医药工业杂志, 2001, 07的方法。 The trans isomer can be partially or completely obtained by high temperature or light, for example, referring to Yang Xiaolong, the conversion of trans-cinnamic acid to cis β-bromo styrene, Chinese Journal of Pharmaceutical Industry, 2001, 07 .
1.2对甲氧基肉桂酸薄荷酯的合成 Synthesis of 1.2 p-methoxy cinnamate menthyl ester
在 100ml单口瓶中加入对甲氧基肉桂酸 (5.00g, 0.028mol),二氯亚砜 (16.75g, 0.14mol), 装上带干燥管的回流冷凝管, 搅拌回流 3h后, 减压除去过量的二氯亚砜, 得到固体 (3)。 加 入 50ml甲苯, L-薄荷醇 (4.4g, 0.028mol), 三乙胺 (2.8g, 0.028mol), 搅拌回流 lh, 停止反应, 抽滤, 滤液浓缩, 柱层析 [V (石油醚): V (乙酸乙酯 )=25 : 1]得到浅黄色油状液体, 固化得到 (l)7.49g, 产率 84.6%。 ^NMRiCDC ), δ: 0·789(3Η, d, J=6.8Hz), 0.902~0.928(7H , m), 0.993~1.118(2H , m), 1.410~1.483(1H , m), 1.886~1.969(1H , m), 1.582(1H , s), 1.671~1.730(2H , m), 2.049(1H, s), 3.840(3H, s), 4.814(1H, d, J=4Hz), 6.305(1H , d, J=16Hz), 6.901(2H , d, J=8.8Hz), 7.482(2H, d, J=8.8Hz), 7.629(1H, d, J=16Hz); ES卜 MSm/z:315{ [ M- H ] } To a 100 ml single-mouth bottle, p-methoxycinnamic acid (5.00 g, 0.028 mol), thionyl chloride (16.75 g, 0.14 mol) was added, and a reflux condenser with a drying tube was placed, and the mixture was stirred for 3 hours, and then removed under reduced pressure. Excess thionyl chloride gave solid (3). 50 ml of toluene, L-menthol (4.4 g, 0.028 mol), triethylamine (2.8 g, 0.028 mol), stirred under reflux for 1 h, quenched the reaction, suction filtered, filtrate concentrated, column chromatography [V ( petroleum ether): V (ethyl acetate) = 25: 1] gave a pale yellow oily solid which solidified to afford (1) 7.49 g. ^NMRiCDC ), δ: 0·789(3Η, d, J=6.8Hz), 0.902~0.928(7H , m), 0.993~1.118(2H , m), 1.410~1.483(1H , m), 1.886~1.969 (1H , m), 1.582(1H , s), 1.671~1.730(2H , m), 2.049(1H, s), 3.840(3H, s), 4.814(1H, d, J=4Hz), 6.305(1H , d, J=16Hz), 6.901(2H , d, J=8.8Hz), 7.482(2H, d, J=8.8Hz), 7.629(1H, d, J=16Hz); ES Bu MSm/z:315 { [ M- H ] }
实施例 2化合物的紫外吸收性能的测定 Determination of the ultraviolet absorption properties of the compound of Example 2
称取 0.1003g化合物 (1), 用无水乙醇溶解并稀释至 100ml ; 吸取该溶液 1ml移入 100ml 容量瓶中; 并稀释至刻度, 配制成质量浓度为 lO g/ml 的化合物 (1)溶液。 以无水乙醇作空 白校正, 用紫外 -可见分光光度计对 1, 在 200nm〜400nm范围内扫描。 0.1003 g of the compound (1) was weighed, dissolved in absolute ethanol and diluted to 100 ml; 1 ml of the solution was pipetted into a 100 ml volumetric flask; and diluted to the mark to prepare a compound (1) solution having a mass concentration of 10 g/ml. Absolute ethanol was used as a blank calibration, and scanned by an ultraviolet-visible spectrophotometer, and scanned in the range of 200 nm to 400 nm.
将 OMC与化合物 3和 4(浓度均为 lO g/ml)均在 200-400nm区间扫描, 可以发现后者在 280〜330nm波段内具有较强的紫外吸收, 在 310nm处的吸收强度达到最大, 其最大吸收波 长为 310.50nm,吸光度为 1.054,摩尔吸光系数为 3.36 X 104L/(mol X cm),见附图 1、 2;而 OMC 的最大吸收波长是 309.50nm, 吸光度为 0.461, 摩尔吸光系数为 1.36 X 104L/(mol X cm), 见附 图 3, 表明化合物 3和 4具有显著较 OMC强的紫外吸收能力, 而且覆盖的紫外波长范围更广, 可以作为潜在的 UVB紫外线吸收剂使用。 实施例 3: 溶解度测试 Scanning both OMC and Compounds 3 and 4 (concentration of 10 g/ml) in the range of 200-400 nm showed that the latter had strong UV absorption in the 280-330 nm band and the maximum absorption at 310 nm. The maximum absorption wavelength is 310.50 nm, the absorbance is 1.054, the molar absorption coefficient is 3.36 X 10 4 L/(mol X cm), see Figures 1 and 2; and the maximum absorption wavelength of OMC is 309.50 nm, and the absorbance is 0.461, Molar The absorption coefficient is 1.36 X 10 4 L/(mol X cm), as shown in Figure 3, indicating that compounds 3 and 4 have significantly higher UV absorption than OMC, and cover a wider range of UV wavelengths, which can be used as a potential UVB UV. Use as an absorbent. Example 3: Solubility test
方法: 参照中国药典 2010年版二部凡例规定的方法, 对本品溶解度进行考察。 称取一 定量研成细粉的供试品,于 25°C ± 2°C条件下置于一定量的容器中,每隔 5分钟强力振摇 30 秒钟; 观察 30分钟内的溶解情况, 如看不见溶质颗粒, 即视为完全溶解。 Method: The solubility of this product was investigated by referring to the methods prescribed in the Chinese Pharmacopoeia 2010 edition. Weigh a certain amount of the test powder into a fine powder, place it in a certain amount of container at 25 ° C ± 2 ° C, shake vigorously for 5 seconds every 5 minutes; observe the dissolution within 30 minutes, If the solute particles are not visible, they are considered to be completely dissolved.
我们对本品在下列溶剂中的溶解度进行了考査:乙醇、水、 0.1mol/L HCI、 O.lmol/L NaOH 水溶液, 化合物 3和 4的溶解度结果见下表。
说 明 书 The solubility of this product in the following solvents was examined: ethanol, water, 0.1 mol/L HCI, O.lmol/L NaOH aqueous solution, and the solubility results of compounds 3 and 4 are shown in the table below. Instruction manual
化合物 3和 4的溶解度试验结果 Solubility test results for compounds 3 and 4
重量 (g) 溶剂 现象 结论 Weight (g) solvent phenomenon conclusion
0.1 乙醇 易溶解 >10% 0.1 Ethanol Easy to dissolve >10%
椰油辛酸癸酸酯 易溶解 >10% Cocoate octanoate phthalate soluble >10%
0.1 0.1
(CETIOLLC) (CETIOLLC)
己二酸二异丙酯 易溶解 >10% Diisopropyl adipate soluble >10%
0.1 0.1
(crodamolDA) (crodamolDA)
0.01 水 不溶 <0.01% 0.01 water insoluble <0.01%
<0.01% <0.01%
0.01 O.lmol/LHCI 不溶 0.01 O.lmol/LHCI insoluble
<0.01% <0.01%
0.01 O.lmol/LNaOH 不溶 0.01 O.lmol/L NaOH insoluble
结论 本品在乙醇、 椰油辛酸癸酸酯 (CETIOLLC)、 己二酸二异丙酯 (crodamolDA)易溶解; 在水、 0.1mol/LHCI、 O.lmol/LNaOH水溶液中不溶, 表明本发明的化合物 3、 4具有具有良好 的化妆性质, 在常见的脂性溶剂中具有良好的溶解度, 以及具有良好的耐水、 耐汗 (滞留)性 质, 而具有优异防晒化妆品潜质。 实施例 4:对甲氧基肉桂酸薄荷酯清凉感觉评价 Conclusion This product is easily soluble in ethanol, cocoate decanoate (CETIOLLC), diisopropyl adipate (crodamolDA); insoluble in water, 0.1mol/L HCI, O.lmol/L NaOH aqueous solution, indicating the invention Compounds 3 and 4 have good cosmetic properties, good solubility in common fat solvents, and good water and sweat resistance (stagnation) properties, and have excellent sunscreen cosmetic potential. Example 4: Evaluation of cooling sensation of menthyl p-methoxycinnamate
受试溶液: 分别取薄荷醇及化合物 (3)、 (4)的对甲氧基肉桂酸薄荷醇酯, 分别配制成 lmg/ml的乙醇溶液; Test solution: menthol and compound (3), (4) p-methoxy cinnamic acid menthol ester, respectively, were prepared into a lmg / ml ethanol solution;
受试者: 10名 19-21岁受试者, 男女各 5名; Subjects: 10 subjects aged 19-21, 5 males and 5 females;
试验方法: 用脱脂棉沾取上述两种乙醇溶液少许, 分别涂于受试者左右前臂内侧, 观 察使用后受试者的反应及皮肤剌激性反应。 所有受试者左手涂饰薄荷酯溶液、 右手涂饰式 (3)、 (4)的对甲氧基肉桂酸薄荷醇酯化合物。 (3)测试完毕后 2小时再测试 (4)。 Test method: Take a small amount of the above two ethanol solutions with absorbent cotton and apply them to the inside of the left and right forearms of the subject respectively to observe the reaction and skin irritation of the subject after use. All subjects were coated with a menthyl ester solution on their left hand and a p-methoxycinnamate menthol ester compound of the formula (3), (4). (3) Test again 2 hours after the test is completed (4).
试验结果的记录: 按照清凉感和清凉感的持续时间将 3个化合物分别按照清凉感: 无 清凉感 (-);微弱清凉感 (+);较强清凉感 (++);很强清凉感: (+++)。 清凉感持续时间: 30分钟、 60分钟、 120分钟 和 120分钟。 Record of test results: According to the duration of coolness and refreshing sensation, the three compounds were respectively in accordance with the cooling sensation: no cooling sensation (-); weak cooling sensation (+); strong cooling sensation (++); strong coolness : (+++). Cooling duration: 30 minutes, 60 minutes, 120 minutes and 120 minutes.
试验结果: test results:
化合物的清凉效果 Cooling effect of the compound
注: 无清凉感: -;微弱清凉感: +;较强清凉感: ++;很强清凉感: +++
说 明 书 Note: No cool feeling: -; Weak cool feeling: +; Strong cool feeling: ++; Strong cool feeling: +++ Instruction manual
分析: 将 lmg/ml 薄荷醇、 对邻氨基苯甲酸薄荷酯及对甲氧基肉桂酸薄荷醇酯的乙醇 溶液涂布后, 薄荷醇在短时间产生明显的剌激效果, 但清凉感很快就消失, 但对邻氨基苯甲 酸薄荷酯及化合物 3和 4可产生持久的清凉作用, 而且效果比较温和, 但是, 化合物 3和 4 的清凉感较邻氨基苯甲酸薄荷酯持续时间更长。 Analysis: After coating lmg/ml menthol, p-menthyl p-aminobenzoate and ethanol solution of p-methoxycinnamate menthol, menthol produced a significant stimulating effect in a short time, but the refreshing feeling was very fast. It disappeared, but the menthyl anthranilate and the compounds 3 and 4 produced a long-lasting cooling effect, and the effect was mild, but the cooling sensation of the compounds 3 and 4 was longer than that of the menthyl anthranilate.
上述测试表明, 本发明的化合物清凉感温和, 剌激性较小, 清凉感的持续时间长, 是 非常理想紫外吸收剂。 实施例 5 The above test shows that the compound of the present invention has a mild cooling feeling, a small irritancy, and a long duration of cooling sensation, and is an ideal ultraviolet absorbing agent. Example 5
本实施例具体公开了一种化妆组合物的配方 This embodiment specifically discloses a formula of a cosmetic composition
组分组成 Component composition
A部分: Part A:
化合物 Compound
阿伏苯宗 Avobenzone
鲸蜡醇 Cetyl alcohol
椰油辛酸癸酸酯 (CETIOLLC) Coconut octanoate (CETIOLLC)
新戊酸异硬脂基酯 Isostearyl pivalate
单硬脂酸二甘醇酯 Diethylene glycol monostearate
对羟基苯甲酸异丁基酯 Isobutyl p-hydroxybenzoate
EDTA-钠盐 EDTA-sodium salt
二乙醇胺十六垸基磷酸酯 B部分 Diethanolamine hexadecanoyl phosphate B part
丙烯酸酯 C10-C30垸基丙烯酸酉 Acrylate C10-C30 mercapto acrylate
去离子水 Deionized water
1,2-丙二醇 1,2-propanediol
氢氧化钾 (10%) 在反应器中将 A部分加热到 85 °C, 然后在 10分钟内缓慢加入 B部分, 接着加入氢氧 化钾, 然后将所得乳液冷却、 脱气即得 0/W型 UV-A和 UV-B复合防晒液。
Potassium Hydroxide (10%) Heat part A to 85 °C in the reactor, then slowly add Part B over 10 minutes, then add potassium hydroxide, then cool and degas the obtained emulsion to get 0/W type. UV-A and UV-B compound sunscreen lotion.
Claims
1.包括顺反异构体或者立体异构体的如下结构的化合物 (1): 1. Compounds with the following structures including cis-trans isomers or stereoisomers (1):
(2) : (2) :
3.下列式 (3)结构的消旋化合物和式 (4) 结构的光学化合物: 3. Racemic compounds with the following structure of formula (3) and optical compounds with the structure of formula (4):
4.一种包含一定量的式 (1)-(4)任选之一化合物作为紫外吸收剂的化妆组合物。 4. A cosmetic composition containing a certain amount of a compound of any one of the formulas (1) to (4) as an ultraviolet absorber.
5.权利要求 4所述的组合物为乳液、 增稠乳液、 乳膏、 凝胶、 溶液、 干粉、 膜剂、 固体 棒、 气雾剂和摩丝。 5. The composition of claim 4 is an emulsion, thickened emulsion, cream, gel, solution, dry powder, film, solid rod, aerosol and mousse.
6.权利要求 4所述式 (1)-(4)化合物的量为 0.5-20wt %。 6. The amount of the compound of formula (1)-(4) described in claim 4 is 0.5-20wt%.
7.权利要求 4的组合物, 其可以包括一种或多种其他 UV-A和 UV-B紫外吸收剂。 7. The composition of claim 4, which may include one or more other UV-A and UV-B ultraviolet absorbers.
8.权利要求 7所述的其他紫外吸收剂包括: 8. Other UV absorbers described in claim 7 include:
下列的有机或无机 UV-A: The following organic or inorganic UV-A:
,丙烯酸酯,包括 2-乙已基 -2-氰基 -3,3-二苯基丙烯酸酯和 2-氰基 -3,3-二苯基丙烯酸乙酯; , acrylates, including 2-ethylhexyl-2-cyano-3,3-diphenylacrylate and ethyl 2-cyano-3,3-diphenylacrylate;
•樟脑衍生物, 包括 4-甲基亚苄基樟脑、 3-亚苄基樟脑、 樟脑苄垸铵硫酸甲酯、 聚丙烯 酰氨基甲基亚苄基樟脑、 硫代亚苄基樟脑、 硫代甲基亚苄基樟脑和对苯二叉基樟脑磺酸; 肉桂酸酯衍生物, 包括甲氧基肉桂酸辛酯、 甲氧基肉桂酸乙氧基乙酯、 甲氧基肉桂酸
权 利 要 求 书 •Camphor derivatives, including 4-methylbenzylidene camphor, 3-benzylidene camphor, camphor benzylidene methyl sulfate, polyacrylamidomethylbenzylidene camphor, thiobenzylidene camphor, thio Methyl benzylidene camphor and p-phenylidene camphorsulfonic acid; cinnamate derivatives, including octyl methoxycinnamate, ethoxyethyl methoxycinnamate, and methoxycinnamic acid Claims
二乙醇胺酯和甲氧基肉桂酸异戊酯; Diethanolamine ester and isoamyl methoxycinnamate;
,对氨基苯甲酸衍生物, 包括对氨基苯甲酸、 对二甲基氨基苯甲酸 2-乙基已酯、 N-氧基 丙烯化的对氨基苯甲酸乙酯、 对氨基苯甲酸甘油酯; , p-aminobenzoic acid derivatives, including p-aminobenzoic acid, 2-ethylhexyl p-dimethylaminobenzoate, N-oxypropylated ethyl p-aminobenzoate, and glyceryl p-aminobenzoate;
*二苯酮, 包括二苯酮 -3、 二苯酮 -4、 2,2',4,4'-四羟基-二苯酮、 2,2'-二羟基 -4,4-二甲氧基 二苯酮; *Benzophenones, including benzophenone-3, benzophenone-4, 2,2',4,4'-tetrahydroxy-benzophenone, 2,2'-dihydroxy-4,4-dimethoxy benzophenone;
•亚苄基丙二酸酯, 包括 4-甲氧基亚苄基丙二酸二 (2-乙基已基)酯; • Benzylidene malonates, including 4-methoxybenzylidene malonate di(2-ethylhexyl) ester;
•2-(4-乙氧基-苯胺基亚甲基) -丙二酸酯,包括 2-(4-乙氧基-苯胺基亚甲基) -丙二酸二乙酯; 有机硅氧垸化合物,包括如欧洲专利公开 EP-BI-0358584、 EP-BI-0538431和 EP-AI-0709080 中描述的亚苄基丙二酸酯; •2-(4-ethoxy-anilinomethylene)-malonate, including 2-(4-ethoxy-anilinomethylene)-malonate diethyl ester; organosiloxane Compounds including benzylidene malonates as described in European patent publications EP-BI-0358584, EP-BI-0538431 and EP-AI-0709080;
•苯并三唑三硅氧垸; •Benzotriazole trisiloxane;
,约 5nm-约 200nm的颜料, 包括二氧化钛颗粒, 其可以进一涂覆氧化铝或氧化锆的金 属氧化物, 或者涂覆多元醇、 甲基硅油、 硬脂酸铝、 垸基硅垸; , pigments with a diameter of about 5nm to about 200nm, including titanium dioxide particles, which can be further coated with metal oxides of aluminum oxide or zirconium oxide, or coated with polyols, methyl silicone oil, aluminum stearate, and alkyl silane;
•咪唑衍生物, 包括 2-苯基苯并咪唑磺酸及其盐; •Imidazole derivatives, including 2-phenylbenzimidazole sulfonic acid and its salts;
•水杨酸酯衍生物, 包括水杨酸异丙基苄酯、 水杨酸苄酯、 水杨酸丁酯、 水杨酸辛酯、 水杨酸异辛酯或水杨酸高孟酯; •Salicylate derivatives, including isopropyl benzyl salicylate, benzyl salicylate, butyl salicylate, octyl salicylate, isooctyl salicylate or homomontethyl salicylate;
•三嗪酮衍生物, 包括辛基三嗪酮、 二辛基丁酰氨基三嗪酮等; •Triazone derivatives, including octyltriazone, dioctylbutylamidotriazone, etc.;
和 /或下列的有机或无机的 UV-B: and/or the following organic or inorganic UV-B:
•二苯甲酰甲垸衍生物, 包括 4-叔丁基 -4'-甲氧基二苯甲酰甲垸、 二甲氧基二苯甲酰基 甲垸、 异丙基二苯甲酰基甲垸; •Dibenzoylformate derivatives, including 4-tert-butyl-4'-methoxydibenzoylformane, dimethoxydibenzoylformane, and isopropyldibenzoylformane ;
•苯并三唑衍生物, 包括 2,2'-亚甲基-二 -(6-(2H-苯并三唑) -2-基) -4-(1,1,3,3-四甲基丁基) - 苯酚; •Benzotriazole derivatives, including 2,2'-methylene-bis-(6-(2H-benzotriazole)-2-yl)-4-(1,1,3,3-tetramethyl Butyl) - phenol;
•亚苯基 -1,4-二苯并咪唑磺酸或盐, 包括 2,2-(1,4-亚苯基) -二 -(IH-苯并咪唑 -4,6-二磺酸); •Phenylene-1,4-dibenzimidazole sulfonic acid or salt, including 2,2-(1,4-phenylene)-bis-(IH-benzimidazole-4,6-disulfonic acid) ;
,氨基取代的羟基二苯酮,包括如欧洲专利公开 EP1046391中描述的 2-(4-二乙基氨基 -2- 羟基-苯甲酰基)—苯甲酸乙酯; , amino-substituted hydroxybenzophenones, including ethyl 2-(4-diethylamino-2-hydroxy-benzoyl)-benzoate as described in European Patent Publication EP1046391;
,约 5nm-约 200nm的颜料, 包括氧化锌颗粒, 其可以进一涂覆氧化铝或氧化锆的金属 氧化物, 或者涂覆多元醇、 甲基硅油、 硬脂酸铝、 垸基硅垸。 , pigments with a diameter of about 5 nm to about 200 nm, including zinc oxide particles, which can be further coated with metal oxides of aluminum oxide or zirconium oxide, or coated with polyol, methyl silicone oil, aluminum stearate, or alkyl silane.
9.权利要求 4-7所述的组合物可以额外含有防腐剂 /抗氧化剂、 脂肪物质 /油、 水、 有机 溶剂、 聚硅氧垸、 增稠剂、 软化剂、 乳化剂、 消泡剂、 保湿剂、 香料、 表面活性剂、 填料、 鳌合剂、 阴离子聚合物、 阳离子聚合物、 非离子聚合物或两性聚合物或其混合物、 推进剂、 酸化剂或碱化剂、 染料、 着色剂、 颜料或纳米颜料。 9. The composition according to claims 4-7 may additionally contain preservatives/antioxidants, fatty substances/oils, water, organic solvents, silicones, thickeners, softeners, emulsifiers, defoaming agents, Humectants, fragrances, surfactants, fillers, chelating agents, anionic polymers, cationic polymers, nonionic polymers or amphoteric polymers or mixtures thereof, propellants, acidulants or alkalizing agents, dyes, colorants, pigments Or nanopigments.
10、权利要求 1-3、 4-7所述化合物或组合物在制备保护人皮肤、头发的防晒剂上的应用。
10. Application of the compound or composition described in claims 1-3 and 4-7 in the preparation of sunscreen agents for protecting human skin and hair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201480040820.1A CN105408301B (en) | 2013-07-17 | 2014-06-27 | With more preferably ultraviolet absorber of ultraviolet protection effectiveness and combinations thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310309324 | 2013-07-17 | ||
CN201310309324.9 | 2013-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015007146A1 true WO2015007146A1 (en) | 2015-01-22 |
Family
ID=52345751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/080941 WO2015007146A1 (en) | 2013-07-17 | 2014-06-27 | Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105408301B (en) |
WO (1) | WO2015007146A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106631788A (en) * | 2016-08-17 | 2017-05-10 | 南京晓庄学院 | Preparation method and application of novel cinnamate ultraviolet absorbents |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109879758A (en) * | 2017-12-06 | 2019-06-14 | 中国科学院大连化学物理研究所 | A kind of sun-proof molecule and application and suncream |
CN109879759A (en) * | 2017-12-06 | 2019-06-14 | 中国科学院大连化学物理研究所 | A kind of sun-proof molecule of methyl cinnamate type and its application and suncream |
CN108159198A (en) * | 2018-03-21 | 2018-06-15 | 亳州市君臣佐使药业有限公司 | A kind of skin eczema external preparation and preparation method thereof |
CN116082939B (en) * | 2022-12-21 | 2023-12-12 | 东莞市雄林新材料科技股份有限公司 | Ultraviolet-proof paint film |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101406442A (en) * | 2008-11-25 | 2009-04-15 | 上海应用技术学院 | Nanometer lipid sun-prevention microparticle suspending liquid and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827508A (en) * | 1996-09-27 | 1998-10-27 | The Procter & Gamble Company | Stable photoprotective compositions |
-
2014
- 2014-06-27 WO PCT/CN2014/080941 patent/WO2015007146A1/en active Application Filing
- 2014-06-27 CN CN201480040820.1A patent/CN105408301B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101406442A (en) * | 2008-11-25 | 2009-04-15 | 上海应用技术学院 | Nanometer lipid sun-prevention microparticle suspending liquid and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
G.S.CHILAYA ET AL.: "New nematic-chiral mixtures for application in thermography", MOLECULAR CRYSTALS AND LIQUID CRYSTALS, vol. 106, no. 1 AND, 31 December 1984 (1984-12-31), pages 69 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106631788A (en) * | 2016-08-17 | 2017-05-10 | 南京晓庄学院 | Preparation method and application of novel cinnamate ultraviolet absorbents |
Also Published As
Publication number | Publication date |
---|---|
CN105408301B (en) | 2018-02-23 |
CN105408301A (en) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69912727T2 (en) | ANIONIC SURFACTANT, UV RADIATION FILTERING COMPOUNDS AND COSMETIC SUN PROTECTION COMPOSITION | |
ES2732182T3 (en) | Antisolar cosmetic compositions based on a synergistic mixture of filters and uses | |
RU2485936C2 (en) | Ester compounds of benzoic acid, composition (versions) and method of composition (versions) obtaining | |
EP1441692B1 (en) | Composition containing an amino acid n-acylated ester and a polyamide-structured uv filter | |
KR101269995B1 (en) | Photo-stable cosmetic or dermatological compositions | |
DE10012408A1 (en) | Use of sunscreen combinations which contain as essential constituent amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations | |
JPH08504184A (en) | A Light-stable perfume cosmetic composition for filtering, which comprises an ultraviolet filtering agent and a benzotriazole silicone-type polymer filtering agent | |
DE10012413A1 (en) | Use of sunscreen combinations containing as essential constituent 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations | |
JP3848308B2 (en) | Composition containing 4-tert-butyl-4'-methoxydibenzoylmethane, 1,3,5-triazine derivative and alkyl (α-cyano) -β, β'-diphenylacrylate and use thereof | |
WO2015007146A1 (en) | Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof | |
DE60207330T2 (en) | Aromatic amide, sulfonamide or carbamate derivatives of acrylonitrile and cosmetic sunscreen compositions containing them | |
JP4829795B2 (en) | Photoprotective composition containing a UV filter based on polysiloxane and having a reduced total amount of UV filter | |
JP2001240525A (en) | Light-protective agent preparation for cosmetics and dermatology | |
JP2002308751A (en) | Use of combination of sunscreening agent as photostable uv filter in cosmetic and pharmaceutical preparation | |
JP2002212043A (en) | Use of combined sun screen as photostable uv filter in cosmetic and medicine | |
JP4180371B2 (en) | Cosmetic anti-sun composition based on a synergistic mixture of screening agents and use thereof | |
JP2008545843A (en) | New polysiloxane sunscreen. | |
ES2341441T3 (en) | ORGANOSILICIDE DERIVATIVES OF AMINO HIDROXIBENZOFENONAS AND ITS USE AS FILTERS OF UV-A RAYS IN COSMETIC PREPARATIONS. | |
JP4565998B2 (en) | sunscreen | |
JP4205013B2 (en) | S-triazine derivatives containing three specific para-aminobenzalmalonate groups, photoprotective cosmetic compositions containing these derivatives, use of said s-triazine derivatives | |
JP4021572B2 (en) | Use of substituted α-methylstyrene derivatives as UV filters, sunscreens and pharmaceutical formulations containing them | |
FR2833167A1 (en) | Use of an amino-substituted 2-hydroxybenzophenone with a benzotriazole and a dibenzoylmethane derivative to produce a synergic improvement in the sun protection factor of composition | |
FR2816842A1 (en) | Insoluble organic particulate compound used for protecting skin and hair against UV-A and UV-B radiation | |
JP2004517096A (en) | Shielding composition containing 1,3,5-triazine derivative, dibenzoylmethane derivative and 4,4-diarylbutadiene compound | |
DE10063867A1 (en) | Compositions for protecting human skin and hair against the damaging effects of ultraviolet radiation, comprise new or known N-substituted anilinomethylene malonic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480040820.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14826775 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14826775 Country of ref document: EP Kind code of ref document: A1 |